In	In	IN	B-PP	O	O
summary	summary	NN	B-NP	O	O
,	,	,	O	O	O
platelet-activating	platelet-activating	JJ	B-NP	B-protein	O
factor	factor	NN	I-NP	I-protein	O
is	be	VBZ	B-VP	O	O
shown	show	VBN	I-VP	O	O
here	here	RB	I-VP	O	O
to	to	TO	I-VP	O	O
have	have	VB	I-VP	O	O
a	a	DT	B-NP	O	O
direct	direct	JJ	I-NP	O	O
and	and	CC	I-NP	O	O
profound	profound	JJ	I-NP	O	O
effect	effect	NN	I-NP	O	O
on	on	IN	B-PP	O	O
a	a	DT	B-NP	O	O
pure	pure	JJ	I-NP	B-cell_line	O
B	B	NN	I-NP	I-cell_line	O
cell	cell	NN	I-NP	I-cell_line	O
line	line	NN	I-NP	I-cell_line	O
.	.	.	O	O	O
Finally	Finally	RB	B-ADVP	O	O
we	we	PRP	B-NP	O	O
explored	explore	VBD	B-VP	O	O
the	the	DT	B-NP	O	O
possible	possible	JJ	I-NP	O	B-SPECCUE
role	role	NN	I-NP	O	O
of	of	IN	B-PP	O	O
5-hydroxyeicosatetraenoic	5-hydroxyeicosatetraenoic	JJ	B-NP	O	O
acid	acid	NN	I-NP	O	O
as	as	IN	B-PP	O	O
a	a	DT	B-NP	O	O
regulator	regulator	NN	I-NP	O	O
of	of	IN	B-PP	O	O
arachidonic	arachidonic	JJ	B-NP	O	O
acid	acid	NN	I-NP	O	O
liberation	liberation	NN	I-NP	O	O
demonstrating	demonstrate	VBG	B-VP	O	O
that	that	IN	B-SBAR	O	O
endogenous	endogenous	JJ	B-NP	B-protein	O
5-lipoxygenase	5-lipoxygenase	NN	I-NP	I-protein	O
activity	activity	NN	I-NP	O	O
modulates	modulate	VBZ	B-VP	O	O
platelet-activating	platelet-activating	JJ	B-NP	B-protein	O
factor	factor	NN	I-NP	I-protein	O
induced	induced	JJ	B-NP	O	O
arachidonic	arachidonic	JJ	I-NP	O	O
acid	acid	NN	I-NP	O	O
release	release	NN	I-NP	O	O
perhaps	perhaps	RB	B-ADVP	O	B-SPECCUE
acting	act	VBG	B-VP	O	O
at	at	IN	B-PP	O	O
the	the	DT	B-NP	O	O
level	level	NN	I-NP	O	O
of	of	IN	B-PP	O	O
phospholipase	phospholipase	NN	B-NP	B-protein	O
A2	A2	NN	I-NP	I-protein	O
.	.	.	O	O	O
Studies	Study	NNS	B-NP	O	O
of	of	IN	B-PP	O	O
the	the	DT	B-NP	O	O
actions	action	NNS	I-NP	O	O
of	of	IN	B-PP	O	O
platelet-activating	platelet-activating	JJ	B-NP	B-protein	O
factor	factor	NN	I-NP	I-protein	O
have	have	VBP	B-VP	O	O
centered	center	VBN	I-VP	O	O
mainly	mainly	RB	B-ADVP	O	O
around	around	IN	B-PP	O	O
neutrophils	neutrophil	NNS	B-NP	B-cell_type	O
,	,	,	O	O	O
monocytes	monocyte	NNS	B-NP	B-cell_type	O
,	,	,	O	O	O
and	and	CC	O	O	O
platelets	platelet	NNS	B-NP	B-cell_type	O
.	.	.	O	O	O
Platelet-activating	Platelet-activating	JJ	B-NP	B-protein	O
factor	factor	NN	I-NP	I-protein	O
is	be	VBZ	B-VP	O	O
a	a	DT	B-NP	O	O
potent	potent	JJ	I-NP	O	O
mediator	mediator	NN	I-NP	O	O
of	of	IN	B-PP	O	O
the	the	DT	B-NP	O	O
inflammatory	inflammatory	JJ	I-NP	O	O
response	response	NN	I-NP	O	O
.	.	.	O	O	O
Platelet-activating	Platelet-activating	JJ	B-NP	B-protein	O
factor	factor	NN	I-NP	I-protein	O
induces	induce	VBZ	B-VP	O	O
phospholipid	phospholipid	JJ	B-NP	O	O
turnover	turnover	NN	I-NP	O	O
,	,	,	O	O	O
calcium	calcium	NN	B-NP	O	O
flux	flux	NN	I-NP	O	O
,	,	,	O	O	O
arachidonic	arachidonic	JJ	B-NP	O	O
acid	acid	NN	I-NP	O	O
liberation	liberation	NN	I-NP	O	O
,	,	,	O	O	O
eicosanoid	eicosanoid	NN	B-NP	O	O
generation	generation	NN	I-NP	O	O
,	,	,	O	O	O
and	and	CC	O	O	O
oncogene	oncogene	NN	B-NP	B-DNA	O
expression	expression	NN	I-NP	O	O
in	in	IN	B-PP	O	O
a	a	DT	B-NP	O	O
human	human	JJ	I-NP	B-cell_line	O
B	B	NN	I-NP	I-cell_line	O
cell	cell	NN	I-NP	I-cell_line	O
line	line	NN	I-NP	I-cell_line	O
.	.	.	O	O	O
We	We	PRP	B-NP	O	O
also	also	RB	B-ADVP	O	O
show	show	VBP	B-VP	O	O
that	that	IN	B-SBAR	O	O
platelet-activating	platelet-activating	JJ	B-NP	B-protein	O
factor	factor	NN	I-NP	I-protein	O
from	from	IN	B-PP	O	O
10	10	CD	B-NP	O	O
-LRB-	(	-LRB-	O	O	O
-12	-12	CD	B-NP	O	O
-RRB-	)	-RRB-	O	O	O
to	to	TO	B-PP	O	O
10	10	CD	B-NP	O	O
-LRB-	(	-LRB-	O	O	O
-6	-6	CD	B-NP	O	O
-RRB-	)	-RRB-	O	O	O
M	M	NN	B-NP	O	O
induced	induce	VBD	B-VP	O	O
rapid	rapid	JJ	B-NP	O	O
and	and	CC	I-NP	O	O
significant	significant	JJ	I-NP	O	O
elevation	elevation	NN	I-NP	O	O
in	in	IN	B-PP	O	O
intracellular	intracellular	JJ	B-NP	O	O
calcium	calcium	NN	I-NP	O	O
levels	level	NNS	I-NP	O	O
,	,	,	O	O	O
whereas	whereas	IN	O	O	O
lyso-platelet-activating	lyso-platelet-activating	JJ	B-NP	B-protein	O
factor	factor	NN	I-NP	I-protein	O
was	be	VBD	B-VP	O	O
again	again	RB	B-ADJP	O	O
ineffective	ineffective	JJ	I-ADJP	O	O
.	.	.	O	O	O
The	The	DT	B-NP	O	O
inactive	inactive	JJ	I-NP	O	O
precursor	precursor	NN	I-NP	O	O
,	,	,	O	O	O
lyso-platelet-activating	lyso-platelet-activating	JJ	B-NP	B-protein	O
factor	factor	NN	I-NP	I-protein	O
,	,	,	O	O	O
at	at	IN	B-PP	O	O
a	a	DT	B-NP	O	O
concentration	concentration	NN	I-NP	O	O
as	as	RB	B-ADJP	O	O
high	high	JJ	I-ADJP	O	O
as	as	IN	B-PP	O	O
10	10	CD	B-NP	O	O
-LRB-	(	-LRB-	O	O	O
-7	-7	CD	B-NP	O	O
-RRB-	)	-RRB-	O	O	O
M	M	NN	B-NP	O	O
had	have	VBD	B-VP	O	O
no	no	DT	B-NP	O	O
effect	effect	NN	I-NP	O	O
on	on	IN	B-PP	O	O
any	any	DT	B-NP	O	O
of	of	IN	B-PP	O	O
the	the	DT	B-NP	O	O
membrane	membrane	NN	I-NP	O	O
phospholipids	phospholipid	NNS	I-NP	O	O
.	.	.	O	O	O
Employing	Employ	VBG	B-VP	O	O
the	the	DT	B-NP	O	O
EBV-transformed	EBV-transformed	JJ	I-NP	B-cell_line	O
human	human	JJ	I-NP	I-cell_line	O
B	B	NN	I-NP	I-cell_line	O
cell	cell	NN	I-NP	I-cell_line	O
line	line	NN	I-NP	I-cell_line	O
SKW6.4	SKW6.4	NN	I-NP	B-cell_line	O
,	,	,	O	O	O
we	we	PRP	B-NP	O	O
demonstrate	demonstrate	VBP	B-VP	O	O
that	that	IN	B-SBAR	O	O
platelet-activating	platelet-activating	JJ	B-NP	B-protein	O
factor	factor	NN	I-NP	I-protein	O
significantly	significantly	RB	B-ADVP	O	O
alters	alter	VBZ	B-VP	O	O
membrane	membrane	NN	B-NP	O	O
phospholipid	phospholipid	NN	I-NP	O	O
metabolism	metabolism	NN	I-NP	O	O
indicated	indicate	VBN	B-VP	O	O
by	by	IN	B-PP	O	O
the	the	DT	B-NP	O	O
incorporation	incorporation	NN	I-NP	O	O
of	of	IN	B-PP	O	O
32P	32P	NN	B-NP	O	O
into	into	IN	B-PP	O	O
phosphatidylcholine	phosphatidylcholine	NN	B-NP	O	O
,	,	,	O	O	O
phosphatidylinositol	phosphatidylinositol	NN	B-NP	O	O
,	,	,	O	O	O
and	and	CC	O	O	O
phosphatidic	phosphatidic	JJ	B-NP	O	O
acid	acid	NN	I-NP	O	O
but	but	CC	B-PP	O	O
not	not	RB	B-ADVP	O	O
significantly	significantly	RB	I-ADVP	O	O
into	into	IN	B-PP	O	O
phosphatidylethanolamine	phosphatidylethanolamine	NN	B-NP	O	O
at	at	IN	B-PP	O	O
concentrations	concentration	NNS	B-NP	O	O
ranging	range	VBG	B-VP	O	O
from	from	IN	B-PP	O	O
10	10	CD	B-NP	O	O
-LRB-	(	-LRB-	O	O	O
-9	-9	CD	B-NP	O	O
-RRB-	)	-RRB-	O	O	O
to	to	TO	B-PP	O	O
10	10	CD	B-NP	O	O
-LRB-	(	-LRB-	O	O	O
-6	-6	CD	B-NP	O	O
-RRB-	)	-RRB-	O	O	O
M	M	NN	B-NP	O	O
.	.	.	O	O	O
In	In	IN	B-PP	O	O
this	this	DT	B-NP	O	O
report	report	NN	I-NP	O	O
we	we	PRP	B-NP	O	O
begin	begin	VBP	B-VP	O	O
to	to	TO	I-VP	O	O
uncover	uncover	VB	I-VP	O	O
the	the	DT	B-NP	O	O
influence	influence	NN	I-NP	O	O
of	of	IN	B-PP	O	O
platelet-activating	platelet-activating	JJ	B-NP	B-protein	O
factor	factor	NN	I-NP	I-protein	O
on	on	IN	B-PP	O	O
B	B	NN	B-NP	B-cell_type	O
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type	O
.	.	.	O	O	O
Moreover	Moreover	RB	B-ADVP	O	O
,	,	,	O	O	O
platelet-activating	platelet-activating	JJ	B-NP	B-protein	O
factor	factor	NN	I-NP	I-protein	O
was	be	VBD	B-VP	O	O
capable	capable	JJ	B-ADJP	O	O
of	of	IN	B-PP	O	O
inducing	induce	VBG	B-VP	O	O
transcription	transcription	NN	B-NP	O	O
of	of	IN	B-PP	O	O
the	the	DT	B-NP	O	O
nuclear	nuclear	JJ	I-NP	B-DNA	O
proto-oncogenes	proto-oncogene	NNS	I-NP	I-DNA	O
c-fos	c-fos	NN	B-NP	B-DNA	O
and	and	CC	O	O	O
c-jun	c-jun	NN	B-NP	B-DNA	O
.	.	.	O	O	O
We	We	PRP	B-NP	O	O
further	further	RB	B-ADVP	O	O
demonstrate	demonstrate	VBP	B-VP	O	O
the	the	DT	B-NP	O	O
impact	impact	NN	I-NP	O	O
of	of	IN	B-PP	O	O
platelet-activating	platelet-activating	JJ	B-NP	B-protein	O
factor	factor	NN	I-NP	I-protein	O
binding	bind	VBG	B-VP	O	O
to	to	TO	B-PP	O	O
B	B	NN	B-NP	B-cell_type	O
cells	cell	NNS	I-NP	I-cell_type	O
by	by	IN	B-PP	O	O
measuring	measure	VBG	B-VP	O	O
platelet-activating	platelet-activating	JJ	B-NP	B-protein	O
factor	factor	NN	I-NP	I-protein	O
induced	induced	JJ	B-NP	O	O
arachidonic	arachidonic	JJ	I-NP	O	O
acid	acid	NN	I-NP	O	O
release	release	NN	I-NP	O	O
and	and	CC	O	O	O
5-hydroxyeicosatetraenoic	5-hydroxyeicosatetraenoic	JJ	B-NP	O	O
acid	acid	NN	I-NP	O	O
production	production	NN	I-NP	O	O
.	.	.	O	O	O
These	These	DT	B-NP	O	O
diurnal	diurnal	JJ	I-NP	O	O
variations	variation	NNS	I-NP	O	O
in	in	IN	B-PP	O	O
GR	GR	NN	B-NP	B-protein	O
might	might	MD	B-VP	O	B-SPECCUE
serve	serve	VB	I-VP	O	O
to	to	TO	I-VP	O	O
coordinate	coordinate	VB	I-VP	O	O
the	the	DT	B-NP	O	O
reactivity	reactivity	NN	I-NP	O	O
of	of	IN	B-PP	O	O
the	the	DT	B-NP	O	O
target	target	NN	I-NP	B-cell_type	O
cells	cell	NNS	I-NP	I-cell_type	O
to	to	TO	B-PP	O	O
cortisol	cortisol	NN	B-NP	O	O
because	because	IN	B-SBAR	O	O
the	the	DT	B-NP	O	O
diurnal	diurnal	JJ	I-NP	O	O
rhythms	rhythm	NNS	I-NP	O	O
of	of	IN	B-PP	O	O
a	a	DT	B-NP	O	O
GR-mediated	GR-mediated	JJ	I-NP	O	O
response	response	NN	I-NP	O	O
,	,	,	O	O	O
the	the	DT	B-NP	O	O
fractional	fractional	JJ	I-NP	O	O
inhibition	inhibition	NN	I-NP	O	O
of	of	IN	B-PP	O	O
chemotactic	chemotactic	JJ	B-NP	O	O
migration	migration	NN	I-NP	O	O
rate	rate	NN	I-NP	O	O
of	of	IN	B-PP	O	O
polymorphonuclear	polymorphonuclear	JJ	B-NP	B-cell_type	O
leukocytes	leukocyte	NNS	I-NP	I-cell_type	O
by	by	IN	B-PP	O	O
cortisol	cortisol	NN	B-NP	O	O
,	,	,	O	O	O
were	be	VBD	B-VP	O	O
found	find	VBN	I-VP	O	O
to	to	TO	I-VP	O	O
be	be	VB	I-VP	O	O
synchronous	synchronous	JJ	B-ADJP	O	O
with	with	IN	B-PP	O	O
those	those	DT	B-NP	O	O
of	of	IN	B-PP	O	O
GR	GR	NN	B-NP	B-protein	O
.	.	.	O	O	O
Thus	Thus	RB	B-ADVP	O	O
,	,	,	O	O	O
we	we	PRP	B-NP	O	O
postulated	postulate	VBD	B-VP	O	B-SPECCUE
that	that	IN	B-SBAR	O	O
the	the	DT	B-NP	O	O
circadian	circadian	JJ	I-NP	O	O
modification	modification	NN	I-NP	O	O
of	of	IN	B-PP	O	O
GR	GR	NN	B-NP	B-protein	O
was	be	VBD	B-VP	O	O
independent	independent	JJ	B-ADJP	O	O
of	of	IN	B-PP	O	O
the	the	DT	B-NP	O	O
diurnal	diurnal	JJ	I-NP	O	O
fluctuations	fluctuation	NNS	I-NP	O	O
in	in	IN	B-PP	O	O
plasma	plasma	NN	B-NP	O	O
cortisol	cortisol	NN	I-NP	O	O
level	level	NN	I-NP	O	O
or	or	CC	O	O	O
the	the	DT	B-NP	O	O
circadian	circadian	JJ	I-NP	O	O
variations	variation	NNS	I-NP	O	O
in	in	IN	B-PP	O	O
environmental	environmental	JJ	B-NP	O	O
lighting	lighting	NN	I-NP	O	O
and	and	CC	O	O	O
that	that	IN	B-SBAR	O	O
the	the	DT	B-NP	O	O
rhythmicity	rhythmicity	NN	I-NP	O	O
might	might	MD	B-VP	O	O
be	be	VB	I-VP	O	O
regulated	regulate	VBN	I-VP	O	O
by	by	IN	B-PP	O	O
the	the	DT	B-NP	O	O
'	'	``	I-NP	O	O
circadian	circadian	JJ	I-NP	O	O
pacemaker	pacemaker	NN	I-NP	O	O
'	'	''	O	O	O
located	located	JJ	B-ADJP	O	O
in	in	IN	B-PP	O	O
the	the	DT	B-NP	O	O
human	human	JJ	I-NP	O	O
basal	basal	JJ	I-NP	O	O
brain	brain	NN	I-NP	O	O
.	.	.	O	O	O
Conversely	Conversely	RB	B-ADVP	O	O
,	,	,	O	O	O
diurnal	diurnal	JJ	B-NP	O	O
rhythmicity	rhythmicity	NN	I-NP	O	O
persisted	persist	VBD	B-VP	O	O
in	in	IN	B-PP	O	O
apoplexy	apoplexy	JJ	B-NP	O	O
patients	patient	NNS	I-NP	O	O
whose	whose	WP$	B-NP	O	O
lesions	lesion	NNS	I-NP	O	O
were	be	VBD	B-VP	O	O
in	in	IN	B-PP	O	O
the	the	DT	B-NP	O	O
cerebral	cerebral	JJ	I-NP	O	O
cortex	cortex	NN	I-NP	O	O
.	.	.	O	O	O
For	For	IN	B-PP	O	O
apoplexic	apoplexic	JJ	B-NP	O	O
patients	patient	NNS	I-NP	O	O
with	with	IN	B-PP	O	O
lesions	lesion	NNS	B-NP	O	O
localized	localized	JJ	B-ADJP	O	O
to	to	TO	B-PP	O	O
the	the	DT	B-NP	O	O
base	base	NN	I-NP	O	O
of	of	IN	B-PP	O	O
the	the	DT	B-NP	O	O
brain	brain	NN	I-NP	O	O
as	as	IN	B-SBAR	O	O
indicated	indicate	VBN	B-VP	O	O
by	by	IN	B-PP	O	O
computerized	computerize	VBN	B-NP	O	O
tomography	tomography	NN	I-NP	O	O
,	,	,	O	O	O
the	the	DT	B-NP	O	O
diurnal	diurnal	JJ	I-NP	O	O
variation	variation	NN	I-NP	O	O
of	of	IN	B-PP	O	O
GR	GR	NN	B-NP	B-protein	O
was	be	VBD	B-VP	O	O
abolished	abolish	VBN	I-VP	O	O
.	.	.	O	O	O
In	In	IN	B-PP	O	O
patients	patient	NNS	B-NP	O	O
suffering	suffer	VBG	B-VP	O	O
from	from	IN	B-PP	O	O
Cushing	Cushing	NN	B-NP	O	O
's	's	POS	B-NP	O	O
syndrome	syndrome	NN	I-NP	O	O
,	,	,	O	O	O
the	the	DT	B-NP	O	O
circadian	circadian	JJ	I-NP	O	O
rhythm	rhythm	NN	I-NP	O	O
of	of	IN	B-PP	O	O
plasma	plasma	NN	B-NP	O	O
cortisol	cortisol	NN	I-NP	O	O
either	either	CC	O	O	B-SPECCUE
disappeared	disappear	VBD	B-VP	O	O
or	or	CC	O	O	B-SPECCUE
was	be	VBD	B-VP	O	O
inverted	invert	VBN	I-VP	O	O
while	while	IN	B-SBAR	O	O
that	that	DT	B-NP	O	O
of	of	IN	B-PP	O	O
GR	GR	NN	B-NP	B-protein	O
did	do	VBD	B-VP	O	O
not	not	RB	I-VP	O	O
significantly	significantly	RB	I-VP	O	O
deviate	deviate	VB	I-VP	O	O
from	from	IN	B-PP	O	O
the	the	DT	B-NP	O	O
normal	normal	JJ	I-NP	O	O
subjects	subject	NNS	I-NP	O	O
.	.	.	O	O	O
In	In	IN	B-PP	O	O
human	human	JJ	B-NP	B-cell_type	O
leukocytes	leukocyte	NNS	I-NP	I-cell_type	O
,	,	,	O	O	O
the	the	DT	B-NP	O	O
peak	peak	JJ	I-NP	O	O
value	value	NN	I-NP	O	O
of	of	IN	B-PP	O	O
GR	GR	NN	B-NP	B-protein	O
was	be	VBD	B-VP	O	O
found	find	VBN	I-VP	O	O
to	to	TO	I-VP	O	O
parallel	parallel	VB	I-VP	O	O
that	that	DT	B-NP	O	O
of	of	IN	B-PP	O	O
plasma	plasma	NN	B-NP	O	O
cortisol	cortisol	NN	I-NP	O	O
with	with	IN	B-PP	O	O
high	high	JJ	B-NP	O	O
and	and	CC	I-NP	O	O
low	low	JJ	I-NP	O	O
values	value	NNS	I-NP	O	O
detected	detect	VBN	B-VP	O	O
at	at	IN	B-PP	O	O
04	04	CD	B-NP	O	O
:	:	:	O	O	O
00-08	00-08	CD	B-NP	O	O
:	:	:	O	O	O
00	00	CD	B-NP	O	O
h	h	NN	I-NP	O	O
and	and	CC	O	O	O
23	23	CD	B-NP	O	O
:	:	:	O	O	O
00-24	00-24	CD	B-NP	O	O
:	:	:	O	O	O
00	00	CD	B-NP	O	O
h	h	NN	I-NP	O	O
,	,	,	O	O	O
respectively	respectively	RB	B-ADVP	O	O
.	.	.	O	O	O
Except	Except	IN	B-PP	O	O
for	for	IN	B-PP	O	O
a	a	DT	B-NP	O	O
4-hour	4-hour	JJ	I-NP	O	O
advancement	advancement	NN	I-NP	O	O
of	of	IN	B-PP	O	O
the	the	DT	B-NP	O	O
peak	peak	NN	I-NP	O	O
,	,	,	O	O	O
a	a	DT	B-NP	O	O
similar	similar	JJ	I-NP	O	O
circadian	circadian	JJ	I-NP	O	O
rhythm	rhythm	NN	I-NP	O	O
of	of	IN	B-PP	O	O
hepatic	hepatic	JJ	B-NP	B-protein	O
GR	GR	NN	I-NP	I-protein	O
was	be	VBD	B-VP	O	O
detected	detect	VBN	I-VP	O	O
in	in	IN	B-PP	O	O
rats	rat	NNS	B-NP	O	O
reared	rear	VBN	B-VP	O	O
under	under	IN	B-PP	O	O
a	a	DT	B-NP	O	O
reversed	reverse	VBN	I-NP	O	O
lighting	lighting	NN	I-NP	O	O
regimen	regimen	NN	I-NP	O	O
-LRB-	(	-LRB-	O	O	O
12D	12D	NN	B-NP	O	O
:	:	:	O	O	O
12L	12L	NN	B-NP	O	O
;	;	:	O	O	O
lights	light	NNS	B-NP	O	O
on	on	IN	B-PP	O	O
between	between	IN	B-NP	O	O
18	18	CD	I-NP	O	O
:	:	:	O	O	O
30	30	CD	B-NP	O	O
and	and	CC	I-NP	O	O
06	06	CD	I-NP	O	O
:	:	:	O	O	O
30	30	CD	B-NP	O	O
h	h	NN	I-NP	O	O
-RRB-	)	-RRB-	O	O	O
.	.	.	O	O	O
For	For	IN	B-PP	O	O
rats	rat	NNS	B-NP	O	O
exposed	expose	VBN	B-VP	O	O
to	to	TO	B-PP	O	O
a	a	DT	B-NP	O	O
natural	natural	JJ	I-NP	O	O
environmental	environmental	JJ	I-NP	O	O
photic	photic	JJ	I-NP	O	O
cycle	cycle	NN	I-NP	O	O
or	or	CC	O	O	O
a	a	DT	B-NP	O	O
12L	12L	NN	I-NP	O	O
:	:	:	I-NP	O	O
12D	12D	NN	I-NP	O	O
artificial	artificial	JJ	I-NP	O	O
light	light	JJ	I-NP	O	O
regime	regime	NN	I-NP	O	O
,	,	,	O	O	O
peak	peak	JJ	B-NP	O	O
values	value	NNS	I-NP	O	O
of	of	IN	B-PP	O	O
hepatic	hepatic	JJ	B-NP	B-protein	O
GR	GR	NN	I-NP	I-protein	O
were	be	VBD	B-VP	O	O
detected	detect	VBN	I-VP	O	O
between	between	IN	B-PP	O	O
23	23	CD	B-NP	O	O
:	:	:	O	O	O
00	00	CD	B-NP	O	O
and	and	CC	I-NP	O	O
02	02	CD	I-NP	O	O
:	:	:	O	O	O
00	00	CD	B-NP	O	O
h	h	NN	I-NP	O	O
.	.	.	O	O	O
Circadian	Circadian	JJ	B-NP	O	O
rhythm	rhythm	NN	I-NP	O	O
in	in	IN	B-PP	O	O
glucocorticoid	glucocorticoid	NN	B-NP	B-protein	O
receptor	receptor	NN	I-NP	I-protein	O
-LRB-	(	-LRB-	O	O	O
GR	GR	NN	B-NP	B-protein	O
-RRB-	)	-RRB-	O	O	O
was	be	VBD	B-VP	O	O
studied	study	VBN	I-VP	O	O
in	in	IN	B-PP	O	O
the	the	DT	B-NP	O	O
rat	rat	NN	I-NP	O	O
liver	liver	NN	I-NP	O	O
and	and	CC	O	O	O
human	human	JJ	B-ADJP	B-cell_type	O
peripheral	peripheral	JJ	I-ADJP	I-cell_type	O
leukocytes	leukocyte	NNS	B-NP	I-cell_type	O
.	.	.	O	O	O
A	A	DT	B-NP	O	O
study	study	NN	I-NP	O	O
on	on	IN	B-PP	O	O
the	the	DT	B-NP	O	O
circadian	circadian	JJ	I-NP	O	O
rhythm	rhythm	NN	I-NP	O	O
of	of	IN	B-PP	O	O
glucocorticoid	glucocorticoid	NN	B-NP	B-protein	O
receptor	receptor	NN	I-NP	I-protein	O
.	.	.	O	O	O
These	These	DT	B-NP	O	O
findings	finding	NNS	I-NP	O	O
suggest	suggest	VBP	B-VP	O	B-SPECCUE
that	that	IN	B-SBAR	O	O
expression	expression	NN	B-NP	O	O
of	of	IN	B-PP	O	O
the	the	DT	B-NP	O	O
1,25-	1,25-	CD	I-NP	B-protein	O
-LRB-	(	-LRB-	O	I-protein	O
OH	OH	NN	B-NP	I-protein	O
-RRB-	)	-RRB-	O	I-protein	O
2D3	2D3	NN	B-NP	I-protein	O
receptor	receptor	NN	I-NP	I-protein	O
in	in	IN	B-PP	O	O
lymphocytes	lymphocyte	NNS	B-NP	B-cell_type	O
is	be	VBZ	B-VP	O	O
triggered	trigger	VBN	I-VP	O	O
by	by	IN	B-PP	O	O
distinct	distinct	JJ	B-NP	O	O
and	and	CC	I-NP	O	O
contingent	contingent	JJ	I-NP	O	O
signals	signal	NNS	I-NP	O	O
,	,	,	O	O	O
and	and	CC	O	O	O
that	that	IN	B-SBAR	O	O
the	the	DT	B-NP	O	O
protein	protein	NN	I-NP	O	O
and	and	CC	O	O	O
the	the	DT	B-NP	O	O
mRNA	mRNA	NN	I-NP	B-RNA	O
encoding	encode	VBG	B-VP	O	O
it	it	PRP	B-NP	O	O
are	be	VBP	B-VP	O	O
identical	identical	JJ	B-ADJP	O	O
to	to	TO	B-PP	O	O
the	the	DT	B-NP	O	O
classical	classical	JJ	I-NP	B-protein	O
vitamin	vitamin	NN	I-NP	I-protein	O
D	D	NN	I-NP	I-protein	O
receptor	receptor	NN	I-NP	I-protein	O
.	.	.	O	O	O
Vitamin	Vitamin	NN	B-NP	B-protein	O
D	D	NN	I-NP	I-protein	O
receptor	receptor	NN	I-NP	I-protein	O
expression	expression	NN	I-NP	O	O
in	in	IN	B-PP	O	O
human	human	JJ	B-NP	B-cell_type	O
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type	O
.	.	.	O	O	O
Lymphocytes	Lymphocyte	NNS	B-NP	B-cell_type	O
activated	activate	VBN	B-VP	O	O
with	with	IN	B-PP	O	O
the	the	DT	B-NP	O	O
OKT3	OKT3	NN	I-NP	B-protein	O
antibody	antibody	NN	I-NP	I-protein	O
to	to	TO	B-PP	O	O
the	the	DT	B-NP	O	O
T-cell	T-cell	NN	I-NP	B-protein	O
antigen	antigen	NN	I-NP	I-protein	O
receptor	receptor	NN	I-NP	I-protein	O
expressed	express	VBD	B-VP	O	O
fewer	few	JJR	B-NP	O	O
binding	bind	VBG	I-NP	O	O
sites	site	NNS	I-NP	O	O
as	as	IN	B-SBAR	O	O
compared	compare	VBN	B-VP	O	O
to	to	TO	B-PP	O	O
lymphocytes	lymphocyte	NNS	B-NP	B-cell_type	O
that	that	WDT	B-NP	O	O
were	be	VBD	B-VP	O	O
activated	activate	VBN	I-VP	O	O
by	by	IN	B-PP	O	O
the	the	DT	B-NP	O	O
polyclonal	polyclonal	JJ	I-NP	O	O
activator	activator	NN	I-NP	O	O
phytohemagglutinin	phytohemagglutinin	NN	I-NP	B-protein	O
-LRB-	(	-LRB-	O	O	O
PHA	PHA	NN	B-NP	B-protein	O
-RRB-	)	-RRB-	O	O	O
.	.	.	O	O	O
However	However	RB	B-ADVP	O	O
,	,	,	O	O	O
combination	combination	NN	B-NP	O	O
of	of	IN	B-PP	O	O
OKT3	OKT3	NN	B-NP	B-protein	O
and	and	CC	O	O	O
phorbol	phorbol	NN	B-NP	O	O
myristate	myristate	NN	I-NP	O	O
acetate	acetate	NN	I-NP	O	O
produced	produce	VBD	B-VP	O	O
a	a	DT	B-NP	O	O
concentration	concentration	NN	I-NP	O	O
of	of	IN	B-PP	O	O
binding	bind	VBG	B-NP	O	O
sites	site	NNS	I-NP	O	O
similar	similar	JJ	B-ADJP	O	O
to	to	TO	B-PP	O	O
the	the	DT	B-NP	O	O
PHA-activated	PHA-activated	JJ	I-NP	B-cell_line	O
cells	cell	NNS	I-NP	I-cell_line	O
.	.	.	O	O	O
The	The	DT	B-NP	O	O
receptor	receptor	NN	I-NP	O	O
from	from	IN	B-PP	O	O
OKT3	OKT3	NN	B-NP	B-protein	O
and	and	CC	I-NP	O	O
OKT3	OKT3	NN	I-NP	B-protein	O
+	+	SYM	O	O	O
phorbol	phorbol	NN	B-NP	O	O
myristate	myristate	NN	I-NP	O	O
acetate-activated	acetate-activated	JJ	B-VP	O	O
lymphocytes	lymphocyte	NNS	B-NP	O	O
exhibited	exhibit	VBD	B-VP	O	O
decreased	decrease	VBN	B-NP	O	O
binding	binding	NN	I-NP	O	O
to	to	TO	B-PP	O	O
DNA-cellulose	DNA-cellulose	NN	B-NP	O	O
compared	compare	VBN	B-VP	O	O
to	to	TO	B-PP	O	O
PHA-activated	PHA-activated	JJ	B-NP	B-cell_type	O
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type	O
.	.	.	O	O	O
In	In	IN	B-PP	O	O
lymphocytes	lymphocyte	NNS	B-NP	B-cell_type	O
activated	activate	VBN	B-VP	O	O
either	either	CC	B-PP	O	O
by	by	IN	I-PP	O	O
PHA	PHA	NN	B-NP	B-protein	O
or	or	CC	O	O	O
OKT3	OKT3	NN	B-NP	B-protein	O
-LRB-	(	-LRB-	B-PP	O	O
but	but	CC	I-PP	O	O
not	not	RB	B-PP	O	O
in	in	IN	I-PP	O	O
resting	rest	VBG	B-NP	B-cell_type	O
cells	cell	NNS	I-NP	I-cell_type	O
-RRB-	)	-RRB-	O	O	O
,	,	,	O	O	O
a	a	DT	B-NP	O	O
50-kDa	50-kDa	JJ	I-NP	B-protein	O
species	specie	NNS	I-NP	I-protein	O
cross-reacting	cross-reacte	VBG	B-VP	O	O
with	with	IN	B-PP	O	O
a	a	DT	B-NP	O	O
monoclonal	monoclonal	JJ	I-NP	B-protein	O
antibody	antibody	NN	I-NP	I-protein	O
against	against	IN	B-PP	O	O
the	the	DT	B-NP	O	O
intestinal	intestinal	JJ	I-NP	B-protein	O
vitamin	vitamin	NN	I-NP	I-protein	O
D	D	NN	I-NP	I-protein	O
receptor	receptor	NN	I-NP	I-protein	O
was	be	VBD	B-VP	O	O
detected	detect	VBN	I-VP	O	O
.	.	.	O	O	O
Finally	Finally	RB	B-ADVP	O	O
,	,	,	O	O	O
RNA	RNA	NN	B-NP	O	O
from	from	IN	B-PP	O	O
activated	activate	VBN	B-NP	B-cell_type	O
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type	O
was	be	VBD	B-VP	O	O
amplified	amplify	VBN	I-VP	O	O
by	by	IN	B-PP	O	O
polymerase	polymerase	NN	B-NP	O	O
chain	chain	NN	I-NP	O	O
reaction	reaction	NN	I-NP	O	O
using	use	VBG	B-VP	O	O
oligonucleotide	oligonucleotide	NN	B-NP	O	O
primers	primer	NNS	I-NP	O	O
flanking	flank	VBG	B-VP	O	O
the	the	DT	B-NP	O	O
196	196	CD	I-NP	B-DNA	O
base	base	NN	I-NP	I-DNA	O
pair	pair	NN	I-NP	I-DNA	O
long	long	JJ	I-NP	I-DNA	O
region	region	NN	I-NP	I-DNA	O
encoding	encode	VBG	B-VP	O	O
the	the	DT	B-NP	O	O
DNA-binding	DNA-binding	JJ	I-NP	B-protein	O
domain	domain	NN	I-NP	I-protein	O
of	of	IN	B-PP	O	O
the	the	DT	B-NP	O	O
human	human	JJ	I-NP	B-protein	O
intestinal	intestinal	JJ	I-NP	I-protein	O
receptor	receptor	NN	I-NP	I-protein	O
.	.	.	O	O	O
The	The	DT	B-NP	O	O
amplified	amplify	VBN	I-NP	O	O
product	product	NN	I-NP	O	O
showed	show	VBD	B-VP	O	O
an	an	DT	B-NP	O	O
identical	identical	JJ	I-NP	B-DNA	O
nucleotide	nucleotide	NN	I-NP	I-DNA	O
sequence	sequence	NN	I-NP	I-DNA	O
to	to	TO	B-PP	O	O
the	the	DT	B-NP	O	O
DNA-binding	DNA-binding	JJ	I-NP	B-protein	O
domain	domain	NN	I-NP	I-protein	O
of	of	IN	B-PP	O	O
the	the	DT	B-NP	O	O
human	human	JJ	I-NP	B-protein	O
intestinal	intestinal	JJ	I-NP	I-protein	O
receptor	receptor	NN	I-NP	I-protein	O
.	.	.	O	O	O
Expression	Expression	NN	B-NP	O	O
of	of	IN	B-PP	O	O
c-jun	c-jun	NN	B-NP	B-DNA	O
,	,	,	O	O	O
jun	jun	NN	B-NP	B-DNA	O
B	B	NN	I-NP	I-DNA	O
and	and	CC	O	O	O
jun	jun	NN	B-NP	B-DNA	O
D	D	NN	I-NP	I-DNA	O
proto-oncogenes	proto-oncogene	NNS	B-NP	I-DNA	O
in	in	IN	B-PP	O	O
human	human	JJ	B-NP	B-cell_type	O
peripheral-blood	peripheral-blood	JJ	I-NP	I-cell_type	O
granulocytes	granulocyte	NNS	I-NP	I-cell_type	O
.	.	.	O	O	O
We	We	PRP	B-NP	O	O
have	have	VBP	B-VP	O	O
found	find	VBN	I-VP	O	O
that	that	IN	B-SBAR	O	O
purified	purify	VBN	B-NP	B-cell_type	O
human	human	JJ	I-NP	I-cell_type	O
peripheral-blood	peripheral-blood	JJ	I-NP	I-cell_type	O
granulocytes	granulocyte	NNS	I-NP	I-cell_type	O
express	express	VBP	B-VP	O	O
constitutively	constitutively	RB	B-NP	O	O
significant	significant	JJ	I-NP	O	O
levels	level	NNS	I-NP	O	O
of	of	IN	B-PP	O	O
proto-oncogenes	proto-oncogene	NNS	B-NP	B-DNA	O
c-jun	c-jun	NN	B-NP	B-RNA	O
,	,	,	O	I-RNA	O
jun	jun	NN	B-NP	I-RNA	O
B	B	NN	I-NP	I-RNA	O
and	and	CC	O	I-RNA	O
jun	jun	NN	B-NP	I-RNA	O
D	D	NN	I-NP	I-RNA	O
mRNA	mRNA	NN	B-NP	I-RNA	O
.	.	.	O	O	O
Upon	Upon	IN	B-PP	O	O
functional	functional	JJ	B-NP	O	O
activation	activation	NN	I-NP	O	O
of	of	IN	B-PP	O	O
granulocytes	granulocyte	NNS	B-NP	B-cell_type	O
by	by	IN	B-PP	O	O
4	4	CD	B-NP	O	O
beta-phorbol	beta-phorbol	NN	I-NP	O	O
12-myristate	12-myristate	NN	I-NP	O	O
13-acetate	13-acetate	NN	I-NP	O	O
-LRB-	(	-LRB-	O	O	O
PMA	PMA	NN	B-NP	O	O
-RRB-	)	-RRB-	O	O	O
,	,	,	O	O	O
the	the	DT	B-NP	O	O
levels	level	NNS	I-NP	O	O
of	of	IN	B-PP	O	O
c-jun	c-jun	NN	B-NP	B-RNA	O
,	,	,	O	I-RNA	O
jun	jun	NN	B-NP	I-RNA	O
B	B	NN	I-NP	I-RNA	O
and	and	CC	O	I-RNA	O
jun	jun	NN	B-NP	I-RNA	O
D	D	NN	I-NP	I-RNA	O
transcripts	transcript	NNS	B-NP	I-RNA	O
were	be	VBD	B-VP	O	O
increased	increase	VBN	I-VP	O	O
.	.	.	O	O	O
The	The	DT	B-NP	O	O
three	three	CD	I-NP	O	O
jun	jun	NN	I-NP	B-DNA	O
genes	gene	NNS	I-NP	I-DNA	O
showed	show	VBD	B-VP	O	O
a	a	DT	B-NP	O	O
similar	similar	JJ	I-NP	O	O
time	time	NN	I-NP	O	O
course	course	NN	I-NP	O	O
in	in	IN	B-PP	O	O
their	their	PRP$	B-NP	O	O
induction	induction	NN	I-NP	O	O
by	by	IN	B-PP	O	O
PMA	PMA	NN	B-NP	O	O
,	,	,	O	O	O
maximal	maximal	JJ	B-NP	O	O
mRNA	mRNA	NN	I-NP	O	O
levels	level	NNS	I-NP	O	O
being	be	VBG	B-VP	O	O
reached	reach	VBN	I-VP	O	O
after	after	IN	B-PP	O	O
60	60	CD	B-NP	O	O
min	min	NN	I-NP	O	O
of	of	IN	B-PP	O	O
induction	induction	NN	B-NP	O	O
.	.	.	O	O	O
These	These	DT	B-NP	O	O
results	result	NNS	I-NP	O	O
suggest	suggest	VBP	B-VP	O	B-SPECCUE
that	that	IN	B-SBAR	O	O
expression	expression	NN	B-NP	O	O
of	of	IN	B-PP	O	O
c-jun	c-jun	NN	B-NP	B-DNA	O
,	,	,	O	O	O
jun	jun	NN	B-NP	B-DNA	O
B	B	NN	I-NP	I-DNA	O
and	and	CC	O	O	O
jun	jun	NN	B-NP	B-DNA	O
D	D	NN	I-NP	I-DNA	O
genes	gene	NNS	B-NP	I-DNA	O
might	might	MD	B-VP	O	O
be	be	VB	I-VP	O	O
involved	involve	VBN	I-VP	O	O
in	in	IN	B-PP	O	O
terminal	terminal	JJ	B-NP	B-cell_type	O
granulocyte	granulocyte	NN	I-NP	I-cell_type	O
differentiation	differentiation	NN	I-NP	O	O
or	or	CC	B-PP	O	O
in	in	IN	B-PP	O	O
regulating	regulate	VBG	B-VP	O	O
granulocyte	granulocyte	NN	B-NP	B-cell_type	O
functionality	functionality	NN	I-NP	O	O
.	.	.	O	O	O
However	However	RB	B-ADVP	O	O
,	,	,	O	O	O
as	as	IN	B-SBAR	O	O
NF-kappa	NF-kappa	NN	B-NP	B-protein	O
B	B	NN	I-NP	I-protein	O
is	be	VBZ	B-VP	O	O
ubiquitous	ubiquitous	JJ	B-ADJP	O	O
and	and	CC	O	O	O
the	the	DT	B-NP	O	O
transcriptional	transcriptional	JJ	I-NP	O	O
activation	activation	NN	I-NP	O	O
through	through	IN	B-PP	O	O
the	the	DT	B-NP	O	O
B2	B2	NN	I-NP	B-DNA	O
site	site	NN	I-NP	I-DNA	O
is	be	VBZ	B-VP	O	O
T	T	NN	B-NP	O	O
cell	cell	NN	I-NP	O	O
specific	specific	JJ	B-ADJP	O	O
,	,	,	O	O	O
yet	yet	RB	B-NP	O	O
another	another	DT	I-NP	O	O
T-cell-specific	T-cell-specific	JJ	I-NP	B-protein	O
factor	factor	NN	I-NP	I-protein	O
which	which	WDT	B-NP	O	O
synergizes	synergize	VBZ	B-VP	O	O
with	with	IN	B-PP	O	O
NF-kappa	NF-kappa	NN	B-NP	B-protein	O
B	B	NN	I-NP	I-protein	O
should	should	MD	B-VP	O	B-SPECCUE
be	be	VB	I-VP	O	O
considered	consider	VBN	I-VP	O	O
.	.	.	O	O	O
Thus	Thus	RB	B-ADVP	O	O
,	,	,	O	O	O
it	it	PRP	B-NP	O	O
appears	appear	VBZ	B-VP	O	B-SPECCUE
that	that	IN	B-SBAR	O	O
the	the	DT	B-NP	O	O
T-cell-specific	T-cell-specific	JJ	I-NP	O	O
activation	activation	NN	I-NP	O	O
of	of	IN	B-PP	O	O
the	the	DT	B-NP	O	O
proenkephalin	proenkephalin	NN	I-NP	B-DNA	O
promoter	promoter	NN	I-NP	I-DNA	O
is	be	VBZ	B-VP	O	O
mediated	mediate	VBN	I-VP	O	O
by	by	IN	B-PP	O	O
NF-kappa	NF-kappa	NN	B-NP	B-protein	O
B	B	NN	I-NP	I-protein	O
.	.	.	O	O	O
Activation	Activation	NN	B-NP	O	O
of	of	IN	B-PP	O	O
T	T	NN	B-NP	B-cell_type	O
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type	O
induces	induce	VBZ	B-VP	O	O
an	an	DT	B-NP	O	O
NF-kappa	NF-kappa	NN	I-NP	O	O
B-like	B-like	JJ	I-NP	O	O
binding	binding	NN	I-NP	O	O
activity	activity	NN	I-NP	O	O
to	to	TO	B-PP	O	O
the	the	DT	B-NP	O	O
B2	B2	NN	I-NP	B-DNA	O
site	site	NN	I-NP	O	O
,	,	,	O	O	O
concomitant	concomitant	JJ	B-ADJP	O	O
with	with	IN	B-PP	O	O
activation	activation	NN	B-NP	O	O
of	of	IN	B-PP	O	O
the	the	DT	B-NP	O	O
proenkephalin	proenkephalin	NN	I-NP	B-DNA	O
promoter	promoter	NN	I-NP	I-DNA	O
.	.	.	O	O	O
The	The	DT	B-NP	O	O
proenkephalin	proenkephalin	NN	I-NP	B-DNA	O
promoter	promoter	NN	I-NP	I-DNA	O
contains	contain	VBZ	B-VP	O	O
a	a	DT	B-NP	O	O
sequence	sequence	NN	I-NP	O	O
GGGGACGTCCCC	GGGGACGTCCCC	NN	I-NP	O	O
,	,	,	O	O	O
named	name	VBN	B-VP	O	O
B2	B2	NN	B-NP	B-protein	O
,	,	,	O	O	O
which	which	WDT	B-NP	O	O
is	be	VBZ	B-VP	O	O
similar	similar	JJ	B-ADJP	O	O
to	to	TO	B-PP	O	O
the	the	DT	B-NP	O	O
kappa	kappa	NN	I-NP	B-DNA	O
B	B	NN	I-NP	I-DNA	O
sequence	sequence	NN	I-NP	I-DNA	O
GGGGACTTTCC	GGGGACTTTCC	NN	I-NP	O	O
,	,	,	O	O	O
the	the	DT	B-NP	O	O
binding	bind	VBG	I-NP	B-DNA	O
site	site	NN	I-NP	I-DNA	O
of	of	IN	B-PP	O	O
the	the	DT	B-NP	O	O
transcription	transcription	NN	I-NP	B-protein	O
factor	factor	NN	I-NP	I-protein	O
nuclear	nuclear	JJ	B-NP	B-protein	O
factor	factor	NN	I-NP	I-protein	O
-LRB-	(	-LRB-	O	I-protein	O
NF	NF	NN	B-NP	I-protein	O
-RRB-	)	-RRB-	O	I-protein	O
-kappa	-kappa	NN	B-NP	I-protein	O
B	B	NN	I-NP	I-protein	O
.	.	.	O	O	O
The	The	DT	B-NP	O	O
purified	purify	VBN	I-NP	O	O
homodimer	homodimer	NN	I-NP	B-protein	O
-LRB-	(	-LRB-	O	O	O
two	two	CD	B-NP	O	O
p50s	p50	NNS	I-NP	B-protein	O
-RRB-	)	-RRB-	O	O	O
of	of	IN	B-PP	O	O
the	the	DT	B-NP	O	O
DNA-binding	DNA-binding	JJ	I-NP	B-protein	O
subunit	subunit	NN	I-NP	I-protein	O
of	of	IN	B-PP	O	O
NF-kappa	NF-kappa	NN	B-NP	B-protein	O
B	B	NN	I-NP	I-protein	O
binds	bind	VBZ	B-VP	O	O
the	the	DT	B-NP	O	O
B2	B2	NN	I-NP	B-DNA	O
site	site	NN	I-NP	O	O
of	of	IN	B-PP	O	O
proenkephalin	proenkephalin	NN	B-NP	O	O
relatively	relatively	RB	B-ADVP	O	O
better	well	RBR	I-ADVP	O	O
than	than	IN	B-SBAR	O	O
does	do	VBZ	O	O	O
the	the	DT	O	O	O
heterotetramer	heterotetramer	NN	B-NP	B-protein	O
-LRB-	(	-LRB-	O	O	O
two	two	CD	B-NP	O	O
p65s	p65	NNS	I-NP	B-protein	O
plus	plus	CC	O	O	O
two	two	CD	B-NP	O	O
p50s	p50	NNS	I-NP	B-protein	O
-RRB-	)	-RRB-	O	O	O
form	form	NN	B-NP	O	O
of	of	IN	B-PP	O	O
the	the	DT	B-NP	O	O
factor	factor	NN	I-NP	O	O
.	.	.	O	O	O
Mutations	Mutation	NNS	B-NP	O	O
at	at	IN	B-PP	O	O
the	the	DT	B-NP	O	O
B2	B2	NN	I-NP	B-DNA	O
site	site	NN	I-NP	O	O
abolish	abolish	VBP	B-VP	O	O
this	this	DT	B-NP	O	O
transcriptional	transcriptional	JJ	I-NP	O	O
activation	activation	NN	I-NP	O	O
.	.	.	O	O	O
Nuclear	Nuclear	JJ	B-NP	B-protein	O
factor	factor	NN	I-NP	I-protein	O
kappa	kappa	NN	I-NP	I-protein	O
B	B	NN	I-NP	I-protein	O
activates	activate	VBZ	B-VP	O	O
proenkephalin	proenkephalin	NN	B-NP	O	O
transcription	transcription	NN	I-NP	O	O
in	in	IN	B-PP	O	O
T	T	NN	B-NP	B-cell_type	O
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type	O
.	.	.	O	O	O
Here	Here	RB	B-ADVP	O	O
we	we	PRP	B-NP	O	O
investigated	investigate	VBD	B-VP	O	O
the	the	DT	B-NP	O	O
transcriptional	transcriptional	JJ	I-NP	O	O
basis	basis	NN	I-NP	O	O
for	for	IN	B-PP	O	O
these	these	DT	B-NP	O	O
changes	change	NNS	I-NP	O	O
.	.	.	O	O	O
Upon	Upon	IN	B-PP	O	O
activation	activation	NN	B-NP	O	O
,	,	,	O	O	O
T	T	NN	B-NP	B-cell_type	O
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type	O
accumulate	accumulate	VBP	B-VP	O	O
high	high	JJ	B-NP	O	O
levels	level	NNS	I-NP	O	O
of	of	IN	B-PP	O	O
the	the	DT	B-NP	O	O
neuropeptide	neuropeptide	NN	I-NP	O	O
enkephalin	enkephalin	NN	I-NP	O	O
which	which	WDT	B-NP	O	O
correlate	correlate	VBP	B-VP	O	O
with	with	IN	B-PP	O	O
high	high	JJ	B-NP	O	O
levels	level	NNS	I-NP	O	O
of	of	IN	B-PP	O	O
proenkephalin	proenkephalin	NN	B-NP	B-RNA	O
mRNA	mRNA	NN	I-NP	I-RNA	O
in	in	IN	B-PP	O	O
the	the	DT	B-NP	O	O
cells	cell	NNS	I-NP	O	O
.	.	.	O	O	O
Further	Further	JJ	B-NP	O	O
studies	study	NNS	I-NP	O	O
are	be	VBP	B-VP	O	O
required	require	VBN	I-VP	O	O
to	to	TO	B-VP	O	O
understand	understand	VB	I-VP	O	O
the	the	DT	B-NP	O	O
physiologic	physiologic	JJ	I-NP	O	O
role	role	NN	I-NP	O	O
of	of	IN	B-PP	O	O
1,25	1,25	CD	B-NP	B-protein	O
-LRB-	(	-LRB-	O	I-protein	O
OH	OH	NN	B-NP	I-protein	O
-RRB-	)	-RRB-	O	I-protein	O
2D3	2D3	NN	B-NP	I-protein	O
receptors	receptor	NNS	I-NP	I-protein	O
in	in	IN	B-PP	O	O
myeloid	myeloid	JJ	B-NP	B-cell_type	O
cells	cell	NNS	I-NP	I-cell_type	O
and	and	CC	O	O	O
proliferating	proliferate	VBG	B-NP	B-cell_type	O
T	T	NN	I-NP	I-cell_type	O
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type	O
.	.	.	O	O	O
Consistent	Consistent	JJ	B-ADJP	O	O
with	with	IN	B-PP	O	O
this	this	DT	B-NP	O	O
short	short	JJ	I-NP	O	O
t1\/2	t1/2	NN	I-NP	O	O
,	,	,	O	O	O
accumulation	accumulation	NN	B-NP	O	O
of	of	IN	B-PP	O	O
1,25	1,25	CD	B-NP	B-RNA	O
-LRB-	(	-LRB-	O	I-RNA	O
OH	OH	NN	B-NP	I-RNA	O
-RRB-	)	-RRB-	O	I-RNA	O
2D3	2D3	NN	B-NP	I-RNA	O
receptor	receptor	NN	I-NP	I-RNA	O
RNA	RNA	NN	I-NP	I-RNA	O
increased	increase	VBD	B-VP	O	O
in	in	IN	B-PP	O	O
cells	cell	NNS	B-NP	O	O
as	as	IN	B-SBAR	O	O
their	their	PRP$	B-NP	O	O
protein	protein	NN	I-NP	O	O
synthesis	synthesis	NN	I-NP	O	O
was	be	VBD	B-VP	O	O
inhibited	inhibit	VBN	I-VP	O	O
.	.	.	O	O	O
Half-life	Half-life	NN	B-NP	O	O
-LRB-	(	-LRB-	O	O	O
t1\/2	t1/2	NN	B-NP	O	O
-RRB-	)	-RRB-	O	O	O
of	of	IN	B-PP	O	O
1,25	1,25	CD	B-NP	B-RNA	O
-LRB-	(	-LRB-	O	I-RNA	O
OH	OH	NN	B-NP	I-RNA	O
-RRB-	)	-RRB-	O	I-RNA	O
2D3	2D3	NN	B-NP	I-RNA	O
receptor	receptor	NN	I-NP	I-RNA	O
RNA	RNA	NN	I-NP	I-RNA	O
in	in	IN	B-PP	O	O
T	T	NN	B-NP	B-cell_type	O
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type	O
was	be	VBD	B-VP	O	O
short	short	JJ	B-ADJP	O	O
-LRB-	(	-LRB-	O	O	O
1	1	CD	B-NP	O	O
hour	hour	NN	I-NP	O	O
-RRB-	)	-RRB-	O	O	O
as	as	IN	B-SBAR	O	O
determined	determine	VBN	B-VP	O	O
by	by	IN	B-PP	O	O
measuring	measure	VBG	B-VP	O	O
decay	decay	NN	B-NP	O	O
of	of	IN	B-PP	O	O
the	the	DT	B-NP	O	O
message	message	NN	I-NP	O	O
after	after	IN	B-PP	O	O
addition	addition	NN	B-NP	O	O
of	of	IN	B-PP	O	O
actinomycin	actinomycin	NN	B-NP	O	O
D	D	NN	I-NP	O	O
.	.	.	O	O	O
with	with	IN	B-PP	O	O
stimulation	stimulation	NN	B-NP	O	O
of	of	IN	B-PP	O	O
proliferation	proliferation	NN	B-NP	O	O
of	of	IN	B-PP	O	O
these	these	DT	B-NP	O	O
cells	cell	NNS	I-NP	O	O
,	,	,	O	O	O
accumulation	accumulation	NN	B-NP	O	O
of	of	IN	B-PP	O	O
1,25	1,25	CD	B-NP	B-RNA	O
-LRB-	(	-LRB-	O	I-RNA	O
OH	OH	NN	B-NP	I-RNA	O
-RRB-	)	-RRB-	O	I-RNA	O
2D3	2D3	NN	B-NP	I-RNA	O
receptor	receptor	NN	I-NP	I-RNA	O
RNA	RNA	NN	I-NP	I-RNA	O
increased	increase	VBD	B-VP	O	O
markedly	markedly	RB	B-ADVP	O	O
.	.	.	O	O	O
In	In	IN	B-PP	O	O
contrast	contrast	NN	B-NP	O	O
,	,	,	O	O	O
nondividing	nondividing	JJ	B-NP	B-cell_type	O
peripheral	peripheral	JJ	I-NP	I-cell_type	O
blood	blood	NN	I-NP	I-cell_type	O
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type	O
from	from	IN	B-PP	O	O
normal	normal	JJ	B-NP	O	O
individuals	individual	NNS	I-NP	O	O
did	do	VBD	B-VP	O	O
not	not	RB	I-VP	O	O
express	express	VB	I-VP	O	O
1,25	1,25	CD	B-NP	B-RNA	O
-LRB-	(	-LRB-	O	I-RNA	O
OH	OH	NN	B-NP	I-RNA	O
-RRB-	)	-RRB-	O	I-RNA	O
2D3	2D3	NN	B-NP	I-RNA	O
receptor	receptor	NN	I-NP	I-RNA	O
RNA	RNA	NN	I-NP	I-RNA	O
;	;	:	O	O	O
Nondividing	Nondivide	VBG	B-VP	O	O
macrophages	macrophage	NNS	B-NP	B-cell_type	O
from	from	IN	B-PP	O	O
normal	normal	JJ	B-NP	O	O
individuals	individual	NNS	I-NP	O	O
also	also	RB	B-ADVP	O	O
expressed	express	VBD	B-VP	O	O
1,25	1,25	CD	B-NP	B-RNA	O
-LRB-	(	-LRB-	O	I-RNA	O
OH	OH	NN	B-NP	I-RNA	O
-RRB-	)	-RRB-	O	I-RNA	O
2D3	2D3	NN	B-NP	I-RNA	O
receptor	receptor	NN	I-NP	I-RNA	O
RNA	RNA	NN	I-NP	I-RNA	O
.	.	.	O	O	O
Steady-state	Steady-state	JJ	B-NP	O	O
levels	level	NNS	I-NP	O	O
of	of	IN	B-PP	O	O
1,25	1,25	CD	B-NP	B-RNA	O
-LRB-	(	-LRB-	O	I-RNA	O
OH	OH	NN	B-NP	I-RNA	O
-RRB-	)	-RRB-	O	I-RNA	O
2D3	2D3	NN	B-NP	I-RNA	O
receptor	receptor	NN	I-NP	I-RNA	O
RNA	RNA	NN	I-NP	I-RNA	O
were	be	VBD	B-VP	O	O
not	not	RB	I-VP	O	O
affected	affect	VBN	I-VP	O	O
by	by	IN	B-PP	O	O
terminal	terminal	JJ	B-NP	O	O
differentiation	differentiation	NN	I-NP	O	O
of	of	IN	B-PP	O	O
HL-60	HL-60	NN	B-NP	B-cell_line	O
toward	toward	IN	B-PP	O	O
either	either	CC	O	O	O
granulocytes	granulocyte	NNS	B-NP	B-cell_type	O
or	or	CC	O	O	O
macrophages	macrophage	NNS	B-NP	B-cell_type	O
.	.	.	O	O	O
Levels	Level	NNS	B-NP	O	O
of	of	IN	B-PP	O	O
occupied	occupy	VBN	B-NP	O	O
1,25	1,25	CD	I-NP	B-protein	O
-LRB-	(	-LRB-	O	I-protein	O
OH	OH	NN	B-NP	I-protein	O
-RRB-	)	-RRB-	O	I-protein	O
2D3	2D3	NN	B-NP	I-protein	O
receptor	receptor	NN	I-NP	I-protein	O
protein	protein	NN	I-NP	I-protein	O
increased	increase	VBD	B-VP	O	O
in	in	IN	B-PP	O	O
these	these	DT	B-NP	O	O
HL-60	HL-60	NN	I-NP	B-cell_line	O
cells	cell	NNS	I-NP	I-cell_line	O
;	;	:	O	O	O
but	but	CC	O	O	O
the	the	DT	B-NP	O	O
total	total	JJ	I-NP	O	O
number	number	NN	I-NP	O	O
of	of	IN	B-PP	O	O
1,25	1,25	CD	B-NP	B-protein	O
-LRB-	(	-LRB-	O	I-protein	O
OH	OH	NN	B-NP	I-protein	O
-RRB-	)	-RRB-	O	I-protein	O
2D3	2D3	NN	B-NP	I-protein	O
receptors	receptor	NNS	I-NP	I-protein	O
decreased	decrease	VBD	B-VP	O	O
about	about	RB	B-NP	O	O
50	50	CD	I-NP	O	O
%	%	NN	I-NP	O	O
at	at	IN	B-PP	O	O
24	24	CD	B-NP	O	O
hours	hour	NNS	I-NP	O	O
and	and	CC	O	O	O
returned	return	VBD	B-VP	O	O
toward	toward	IN	B-PP	O	O
normal	normal	JJ	B-NP	O	O
at	at	IN	B-PP	O	O
72	72	CD	B-NP	O	O
hours	hour	NNS	I-NP	O	O
.	.	.	O	O	O
Levels	Level	NNS	B-NP	O	O
of	of	IN	B-PP	O	O
RNA	RNA	NN	B-NP	O	O
coding	coding	NN	I-NP	O	O
for	for	IN	B-PP	O	O
the	the	DT	B-NP	O	O
receptor	receptor	NN	I-NP	O	O
were	be	VBD	B-VP	O	O
not	not	RB	I-VP	O	O
modulated	modulate	VBN	I-VP	O	O
by	by	IN	B-PP	O	O
exposure	exposure	NN	B-NP	O	O
to	to	TO	B-PP	O	O
high	high	JJ	B-NP	O	O
levels	level	NNS	I-NP	O	O
of	of	IN	B-PP	O	O
ligand	ligand	NN	B-NP	O	O
.	.	.	O	O	O
HL-60	HL-60	NN	B-NP	B-cell_line	O
cells	cell	NNS	I-NP	I-cell_line	O
were	be	VBD	B-VP	O	O
cultured	culture	VBN	I-VP	O	O
with	with	IN	B-PP	O	O
10	10	CD	B-NP	O	O
-LRB-	(	-LRB-	O	O	O
-7	-7	CD	B-NP	O	O
-RRB-	)	-RRB-	O	O	O
mol\/L	mol/L	NN	B-NP	O	O
1,25	1,25	CD	I-NP	O	O
-LRB-	(	-LRB-	O	O	O
OH	OH	NN	B-NP	O	O
-RRB-	)	-RRB-	O	O	O
2D3	2D3	NN	B-NP	O	O
for	for	IN	B-PP	O	O
24	24	CD	B-NP	O	O
to	to	TO	I-NP	O	O
72	72	CD	I-NP	O	O
hours	hour	NNS	I-NP	O	O
,	,	,	O	O	O
and	and	CC	O	O	O
levels	level	NNS	B-NP	O	O
of	of	IN	B-PP	O	O
expression	expression	NN	B-NP	O	O
of	of	IN	B-PP	O	O
1,25	1,25	CD	B-NP	B-protein	O
-LRB-	(	-LRB-	O	I-protein	O
OH	OH	NN	B-NP	I-protein	O
-RRB-	)	-RRB-	O	I-protein	O
2D3	2D3	NN	B-NP	I-protein	O
receptor	receptor	NN	I-NP	I-protein	O
and	and	CC	O	O	O
its	its	PRP$	B-NP	O	O
RNA	RNA	NN	I-NP	O	O
were	be	VBD	B-VP	O	O
examined	examine	VBN	I-VP	O	O
.	.	.	O	O	O
Receptor	Receptor	NN	B-NP	B-RNA	O
transcripts	transcript	NNS	I-NP	I-RNA	O
were	be	VBD	B-VP	O	O
4.6	4.6	CD	B-NP	O	O
kilobases	kilobas	NNS	B-NP	O	O
-LRB-	(	-LRB-	O	O	O
kb	kb	NN	B-NP	O	O
-RRB-	)	-RRB-	O	O	O
,	,	,	O	O	O
and	and	CC	O	O	O
no	no	DT	B-NP	O	O
variant	variant	JJ	I-NP	O	O
sizes	size	NNS	I-NP	O	O
were	be	VBD	B-VP	O	O
observed	observe	VBN	I-VP	O	O
.	.	.	O	O	O
Constitutive	Constitutive	JJ	B-NP	O	O
expression	expression	NN	I-NP	O	O
of	of	IN	B-PP	O	O
1,25	1,25	CD	B-NP	B-RNA	O
-LRB-	(	-LRB-	O	I-RNA	O
OH	OH	NN	B-NP	I-RNA	O
-RRB-	)	-RRB-	O	I-RNA	O
2D3	2D3	NN	B-NP	I-RNA	O
receptor	receptor	NN	I-NP	I-RNA	O
RNA	RNA	NN	I-NP	I-RNA	O
was	be	VBD	B-VP	O	O
detected	detect	VBN	I-VP	O	O
in	in	IN	B-PP	O	O
various	various	JJ	B-NP	O	O
kinds	kind	NNS	I-NP	O	O
of	of	IN	B-PP	O	O
hematopoietic	hematopoietic	JJ	B-NP	B-cell_type	O
cells	cell	NNS	I-NP	I-cell_type	O
,	,	,	O	O	O
including	include	VBG	B-PP	O	O
macrophages	macrophage	NNS	B-NP	B-cell_type	O
and	and	CC	O	O	O
activated	activate	VBN	B-NP	O	O
T	T	NN	I-NP	B-cell_type	O
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type	O
,	,	,	O	O	O
as	as	RB	B-CONJP	O	O
well	well	RB	I-CONJP	O	O
as	as	IN	I-CONJP	O	O
in	in	IN	B-PP	O	O
cell	cell	NN	B-NP	O	O
lines	line	NNS	I-NP	O	O
KG-1	KG-1	NN	B-NP	B-cell_line	O
-LRB-	(	-LRB-	O	O	O
myeloblasts	myeloblast	NNS	B-NP	B-cell_type	O
-RRB-	)	-RRB-	O	O	O
,	,	,	O	O	O
HL-60	HL-60	NN	B-NP	B-cell_line	O
-LRB-	(	-LRB-	O	O	O
promyelocytes	promyelocyte	NNS	B-NP	B-cell_line	O
-RRB-	)	-RRB-	O	O	O
,	,	,	O	O	O
ML-3	ML-3	NN	B-NP	B-cell_line	O
-LRB-	(	-LRB-	O	O	O
myelomonoblasts	myelomonoblast	NNS	B-NP	B-cell_line	O
-RRB-	)	-RRB-	O	O	O
,	,	,	O	O	O
U937	U937	NN	B-NP	B-cell_line	O
,	,	,	O	O	O
THP-1	THP-1	NN	B-NP	B-cell_line	O
-LRB-	(	-LRB-	O	O	O
monoblasts	monoblast	NNS	B-NP	B-cell_line	O
-RRB-	)	-RRB-	O	O	O
,	,	,	O	O	O
K562	K562	NN	B-NP	B-cell_line	O
-LRB-	(	-LRB-	O	O	O
erythroblasts	erythroblast	NNS	B-NP	B-cell_type	O
-RRB-	)	-RRB-	O	O	O
,	,	,	O	O	O
and	and	CC	O	O	O
S-LB1	S-LB1	NN	B-NP	B-cell_line	O
-LRB-	(	-LRB-	O	O	O
HTLV-1-transfected	HTLV-1-transfected	JJ	B-NP	B-cell_type	O
T	T	NN	I-NP	I-cell_type	O
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type	O
-RRB-	)	-RRB-	O	O	O
.	.	.	O	O	O
We	We	PRP	B-NP	O	O
examined	examine	VBD	B-VP	O	O
the	the	DT	B-NP	O	O
expression	expression	NN	B-NP	O	O
and	and	CC	O	O	O
modulation	modulation	NN	B-NP	O	O
of	of	IN	B-PP	O	O
expression	expression	NN	B-NP	O	O
of	of	IN	B-PP	O	O
1,25	1,25	CD	B-NP	B-RNA	O
-LRB-	(	-LRB-	O	I-RNA	O
OH	OH	NN	B-NP	I-RNA	O
-RRB-	)	-RRB-	O	I-RNA	O
2D3	2D3	NN	B-NP	I-RNA	O
receptor	receptor	NN	I-NP	I-RNA	O
RNA	RNA	NN	I-NP	I-RNA	O
in	in	IN	B-PP	O	O
various	various	JJ	B-NP	O	O
proliferating	proliferate	VBG	I-NP	O	O
and	and	CC	I-NP	O	O
nonproliferating	nonproliferating	JJ	I-NP	B-cell_type	O
hematopoietic	hematopoietic	JJ	I-NP	I-cell_type	O
cells	cell	NNS	I-NP	I-cell_type	O
.	.	.	O	O	O
Little	Little	JJ	B-NP	O	O
is	be	VBZ	B-VP	O	O
known	know	VBN	I-VP	O	O
of	of	IN	B-PP	O	O
expression	expression	NN	B-NP	O	O
of	of	IN	B-PP	O	O
1,25	1,25	CD	B-NP	B-RNA	O
-LRB-	(	-LRB-	O	I-RNA	O
OH	OH	NN	B-NP	I-RNA	O
-RRB-	)	-RRB-	O	I-RNA	O
2D3	2D3	NN	B-NP	I-RNA	O
receptor	receptor	NN	I-NP	I-RNA	O
RNA	RNA	NN	I-NP	I-RNA	O
in	in	IN	B-PP	O	O
hematopoietic	hematopoietic	JJ	B-NP	B-cell_type	O
cells	cell	NNS	I-NP	I-cell_type	O
.	.	.	O	O	O
these	these	DT	B-NP	O	O
effects	effect	NNS	I-NP	O	O
are	be	VBP	B-VP	O	O
probably	probably	RB	I-VP	O	B-SPECCUE
mediated	mediate	VBN	I-VP	O	O
through	through	IN	B-PP	O	O
the	the	DT	B-NP	O	O
1,25	1,25	CD	I-NP	B-protein	O
-LRB-	(	-LRB-	O	I-protein	O
OH	OH	NN	B-NP	I-protein	O
-RRB-	)	-RRB-	O	I-protein	O
2D3	2D3	NN	B-NP	I-protein	O
receptor	receptor	NN	I-NP	I-protein	O
.	.	.	O	O	O
Most	Most	JJS	B-NP	O	O
B	B	NN	I-NP	B-cell_line	O
lymphocyte	lymphocyte	NN	I-NP	I-cell_line	O
lines	line	NNS	I-NP	I-cell_line	O
expressed	express	VBD	B-VP	O	O
negligible	negligible	JJ	B-NP	O	O
levels	level	NNS	I-NP	O	O
of	of	IN	B-PP	O	O
1,25	1,25	CD	B-NP	B-RNA	O
-LRB-	(	-LRB-	O	I-RNA	O
OH	OH	NN	B-NP	I-RNA	O
-RRB-	)	-RRB-	O	I-RNA	O
2D3	2D3	NN	B-NP	I-RNA	O
receptor	receptor	NN	I-NP	I-RNA	O
RNA	RNA	NN	I-NP	I-RNA	O
and	and	CC	I-NP	O	O
protein	protein	NN	I-NP	O	O
;	;	:	O	O	O
however	however	RB	O	O	O
;	;	:	O	O	O
analysis	analysis	NN	B-NP	O	O
of	of	IN	B-PP	O	O
a	a	DT	B-NP	O	O
lymphoid\/myeloid	lymphoid/myeloid	JJ	I-NP	B-cell_line	O
somatic	somatic	JJ	I-NP	I-cell_line	O
hybrid	hybrid	NN	I-NP	I-cell_line	O
suggested	suggest	VBD	B-VP	O	B-SPECCUE
that	that	IN	B-SBAR	O	O
suppression	suppression	NN	B-NP	O	O
of	of	IN	B-PP	O	O
expression	expression	NN	B-NP	O	O
of	of	IN	B-PP	O	O
1,25	1,25	CD	B-NP	B-RNA	O
-LRB-	(	-LRB-	O	I-RNA	O
OH	OH	NN	B-NP	I-RNA	O
-RRB-	)	-RRB-	O	I-RNA	O
2D3	2D3	NN	B-NP	I-RNA	O
receptor	receptor	NN	I-NP	I-RNA	O
RNA	RNA	NN	I-NP	I-RNA	O
in	in	IN	B-PP	O	O
B	B	NN	B-NP	B-cell_type	O
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type	O
may	may	MD	B-VP	O	O
be	be	VB	I-VP	O	O
a	a	DT	B-NP	O	O
dominant	dominant	JJ	I-NP	O	O
characteristic	characteristic	NN	I-NP	O	O
.	.	.	O	O	O
All	All	DT	B-NP	O	O
cell	cell	NN	I-NP	B-cell_line	O
lines	line	NNS	I-NP	I-cell_line	O
examined	examine	VBN	B-VP	O	O
in	in	IN	B-PP	O	O
this	this	DT	B-NP	O	O
group	group	NN	I-NP	O	O
also	also	RB	B-ADVP	O	O
expressed	express	VBD	B-VP	O	O
1,25	1,25	CD	B-NP	B-protein	O
-LRB-	(	-LRB-	O	I-protein	O
OH	OH	NN	B-NP	I-protein	O
-RRB-	)	-RRB-	O	I-protein	O
2D3	2D3	NN	B-NP	I-protein	O
receptors	receptor	NNS	I-NP	I-protein	O
.	.	.	O	O	O
In	In	IN	B-PP	O	O
fact	fact	NN	B-NP	O	O
,	,	,	O	O	O
transgenic	transgenic	JJ	B-NP	B-cell_type	O
bone	bone	NN	I-NP	I-cell_type	O
marrow	marrow	NN	I-NP	I-cell_type	O
cells	cell	NNS	I-NP	I-cell_type	O
cocultured	coculture	VBN	B-VP	O	O
with	with	IN	B-PP	O	O
a	a	DT	B-NP	O	O
bone	bone	NN	I-NP	B-cell_line	O
marrow-derived	marrow-derived	JJ	I-NP	I-cell_line	O
stromal	stromal	JJ	I-NP	I-cell_line	O
cell	cell	NN	I-NP	I-cell_line	O
line	line	NN	I-NP	I-cell_line	O
revealed	reveal	VBD	B-VP	O	O
an	an	DT	B-NP	O	O
altered	altered	JJ	I-NP	O	O
B-cell	B-cell	NN	I-NP	O	O
maturation	maturation	NN	I-NP	O	O
pattern	pattern	NN	I-NP	O	O
.	.	.	O	O	O
Preparation	Preparation	NN	B-NP	O	O
and	and	CC	O	O	O
analysis	analysis	NN	B-NP	O	O
of	of	IN	B-PP	O	O
bone	bone	NN	B-NP	B-cell_type	O
marrow	marrow	NN	I-NP	I-cell_type	O
cells	cell	NNS	I-NP	I-cell_type	O
from	from	IN	B-PP	O	O
the	the	DT	B-NP	O	O
chimeric	chimeric	JJ	I-NP	O	O
mice	mouse	NNS	I-NP	O	O
indicated	indicate	VBD	B-VP	O	B-SPECCUE
that	that	IN	B-SBAR	O	I-SPECCUE
the	the	DT	B-NP	O	O
bone	bone	NN	I-NP	O	O
marrow	marrow	NN	I-NP	O	O
is	be	VBZ	B-VP	O	O
the	the	DT	B-NP	O	O
effective	effective	JJ	I-NP	O	O
site	site	NN	I-NP	O	O
for	for	IN	B-PP	O	O
specific	specific	JJ	B-NP	O	O
depletion	depletion	NN	I-NP	O	O
of	of	IN	B-PP	O	O
the	the	DT	B-NP	O	O
B-cell	B-cell	NN	I-NP	B-cell_type	O
population	population	NN	I-NP	I-cell_type	O
.	.	.	O	O	O
In	In	IN	B-PP	O	O
the	the	DT	B-NP	O	O
transgenic	transgenic	JJ	I-NP	O	O
mice	mouse	NNS	I-NP	O	O
,	,	,	O	O	O
all	all	PDT	B-NP	O	O
the	the	DT	I-NP	O	O
lymphoid	lymphoid	JJ	I-NP	O	O
tissues	tissue	NNS	I-NP	O	O
examined	examine	VBN	B-VP	O	O
showed	show	VBD	B-VP	O	O
a	a	DT	B-NP	O	O
dramatic	dramatic	JJ	I-NP	O	O
reduction	reduction	NN	I-NP	O	O
in	in	IN	B-PP	O	O
the	the	DT	B-NP	O	O
number	number	NN	I-NP	O	O
of	of	IN	B-PP	O	O
B	B	NN	B-NP	B-cell_type	O
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type	O
-LRB-	(	-LRB-	O	O	O
B	B	NN	B-NP	B-cell_type	O
cells	cell	NNS	I-NP	I-cell_type	O
-RRB-	)	-RRB-	O	O	O
.	.	.	O	O	O
In	In	IN	B-PP	O	O
this	this	DT	B-NP	O	O
study	study	NN	I-NP	O	O
,	,	,	O	O	O
we	we	PRP	B-NP	O	O
generated	generate	VBD	B-VP	O	O
transgenic	transgenic	JJ	B-NP	O	O
mice	mouse	NNS	I-NP	O	O
carrying	carry	VBG	B-VP	O	O
the	the	DT	B-NP	O	O
human	human	JJ	I-NP	B-DNA	O
IRF-1	IRF-1	NN	I-NP	I-DNA	O
gene	gene	NN	I-NP	I-DNA	O
linked	link	VBN	B-VP	O	O
to	to	TO	B-PP	O	O
the	the	DT	B-NP	O	O
human	human	JJ	I-NP	B-DNA	O
immunoglobulin	immunoglobulin	NN	I-NP	I-DNA	O
heavy-chain	heavy-chain	JJ	I-NP	I-DNA	O
enhancer	enhancer	NN	I-NP	I-DNA	O
.	.	.	O	O	O
Since	Since	IN	B-SBAR	O	O
the	the	DT	B-NP	O	O
IRF-1	IRF-1	NN	I-NP	B-DNA	O
gene	gene	NN	I-NP	I-DNA	O
is	be	VBZ	B-VP	O	O
both	both	CC	O	O	O
virus	virus	NN	B-NP	O	O
and	and	CC	O	O	O
IFN	IFN	NN	B-NP	B-protein	O
inducible	inducible	JJ	B-ADJP	O	O
,	,	,	O	O	O
an	an	DT	B-NP	O	O
intriguing	intriguing	JJ	I-NP	O	O
issue	issue	NN	I-NP	O	B-SPECCUE
is	be	VBZ	B-VP	O	I-SPECCUE
raised	raise	VBN	I-VP	O	I-SPECCUE
as	as	IN	B-PP	O	O
to	to	TO	I-PP	O	O
whether	whether	IN	B-SBAR	O	O
the	the	DT	B-NP	O	O
IRF-1	IRF-1	NN	I-NP	B-DNA	O
gene	gene	NN	I-NP	I-DNA	O
is	be	VBZ	B-VP	O	O
functioning	function	VBG	I-VP	O	O
in	in	IN	B-PP	O	O
IFN-mediated	IFN-mediated	JJ	B-NP	O	O
regulation	regulation	NN	I-NP	O	O
of	of	IN	B-PP	O	O
cell	cell	NN	B-NP	O	O
growth	growth	NN	B-NP	O	O
and	and	CC	O	O	O
differentiation	differentiation	NN	B-NP	O	O
.	.	.	O	O	O
Previously	Previously	RB	B-ADVP	O	O
,	,	,	O	O	O
a	a	DT	B-NP	O	O
nuclear	nuclear	JJ	I-NP	B-protein	O
factor	factor	NN	I-NP	I-protein	O
,	,	,	O	O	O
IRF-1	IRF-1	NN	B-NP	B-protein	O
-LRB-	(	-LRB-	O	O	O
interferon	interferon	NN	B-NP	B-protein	O
regulatory	regulatory	JJ	I-NP	I-protein	O
factor	factor	NN	I-NP	I-protein	O
1	1	CD	I-NP	I-protein	O
-RRB-	)	-RRB-	O	O	O
,	,	,	O	O	O
which	which	WDT	B-NP	O	O
binds	bind	VBZ	B-VP	O	O
to	to	TO	B-PP	O	O
type	type	NN	B-NP	B-protein	O
I	I	CD	I-NP	I-protein	O
IFN	IFN	NN	I-NP	I-protein	O
and	and	CC	O	O	O
some	some	DT	B-NP	O	O
IFN-inducible	IFN-inducible	JJ	I-NP	B-DNA	O
gene	gene	NN	I-NP	I-DNA	O
promoters	promoter	NNS	I-NP	I-DNA	O
,	,	,	O	O	O
was	be	VBD	B-VP	O	O
identified	identify	VBN	I-VP	O	O
and	and	CC	O	O	O
cloned	clone	VBN	B-VP	O	O
.	.	.	O	O	O
In	In	IN	B-PP	O	O
fact	fact	NN	B-NP	O	O
,	,	,	O	O	O
IFNs	IFN	NNS	B-NP	B-protein	O
inhibit	inhibit	VBP	B-VP	O	O
growth	growth	NN	B-NP	O	O
of	of	IN	B-PP	O	O
various	various	JJ	B-NP	O	O
normal	normal	JJ	I-NP	O	O
and	and	CC	I-NP	O	O
transformed	transform	VBN	I-NP	B-cell_type	O
cell	cell	NN	I-NP	I-cell_type	O
types	type	NNS	I-NP	I-cell_type	O
.	.	.	O	O	O
Interferons	Interferon	NNS	B-NP	B-protein	O
-LRB-	(	-LRB-	O	O	O
IFNs	IFN	NNS	B-NP	B-protein	O
-RRB-	)	-RRB-	O	O	O
are	be	VBP	B-VP	O	O
well	well	RB	I-VP	O	O
known	know	VBN	I-VP	O	O
both	both	CC	O	O	O
as	as	IN	B-PP	O	O
antiviral	antiviral	JJ	B-NP	B-protein	O
proteins	protein	NNS	I-NP	I-protein	O
and	and	CC	B-PP	O	O
as	as	IN	B-PP	O	O
potent	potent	JJ	B-NP	O	O
regulators	regulator	NNS	I-NP	O	O
of	of	IN	B-PP	O	O
cell	cell	NN	B-NP	O	O
growth	growth	NN	B-NP	O	O
and	and	CC	O	O	O
differentiation	differentiation	NN	B-NP	O	O
.	.	.	O	O	O
Specific	Specific	JJ	B-NP	O	O
depletion	depletion	NN	I-NP	O	O
of	of	IN	B-PP	O	O
the	the	DT	B-NP	O	O
B-cell	B-cell	NN	I-NP	B-cell_line	O
population	population	NN	I-NP	I-cell_line	O
induced	induce	VBN	B-VP	O	O
by	by	IN	B-PP	O	O
aberrant	aberrant	JJ	B-NP	O	O
expression	expression	NN	I-NP	O	O
of	of	IN	B-PP	O	O
human	human	JJ	B-NP	B-DNA	O
interferon	interferon	NN	I-NP	I-DNA	O
regulatory	regulatory	JJ	I-NP	I-DNA	O
factor	factor	NN	I-NP	I-DNA	O
1	1	CD	I-NP	I-DNA	O
gene	gene	NN	I-NP	I-DNA	O
in	in	IN	B-PP	O	O
transgenic	transgenic	JJ	B-NP	O	O
mice	mouse	NNS	I-NP	O	O
.	.	.	O	O	O
The	The	DT	B-NP	O	O
rate	rate	NN	I-NP	O	O
of	of	IN	B-PP	O	O
LTR-directed	LTR-directed	JJ	B-NP	B-DNA	O
gene	gene	NN	I-NP	I-DNA	O
expression	expression	NN	I-NP	O	O
increased	increase	VBD	B-VP	O	O
in	in	IN	B-PP	O	O
response	response	NN	I-PP	O	O
to	to	TO	I-PP	O	O
treatment	treatment	NN	B-NP	O	O
with	with	IN	B-PP	O	O
either	either	CC	O	O	O
a	a	DT	B-NP	O	O
phorbol	phorbol	NN	I-NP	O	O
ester	ester	NN	I-NP	O	O
or	or	CC	O	O	O
tumor	tumor	NN	B-NP	B-protein	O
necrosis	necrosis	NN	I-NP	I-protein	O
factor	factor	NN	I-NP	I-protein	O
alpha	alpha	NN	I-NP	I-protein	O
if	if	IN	B-SBAR	O	O
either	either	CC	O	O	O
the	the	DT	O	O	O
NFAT-1	NFAT-1	NN	B-NP	B-protein	O
or	or	CC	O	O	O
NF	NF	NN	B-NP	B-DNA	O
kappa	kappa	NN	I-NP	I-DNA	O
B	B	NN	I-NP	I-DNA	O
binding	binding	NN	I-NP	I-DNA	O
sites	site	NNS	I-NP	I-DNA	O
were	be	VBD	B-VP	O	O
deleted	delete	VBN	I-VP	O	O
,	,	,	O	O	O
but	but	CC	O	O	O
failed	fail	VBD	B-VP	O	O
to	to	TO	I-VP	O	O
respond	respond	VB	I-VP	O	O
to	to	TO	B-PP	O	O
these	these	DT	B-NP	O	O
mitogenic	mitogenic	JJ	I-NP	O	O
stimuli	stimulus	NNS	I-NP	O	O
if	if	IN	B-SBAR	O	O
both	both	DT	B-NP	O	O
sequences	sequence	NNS	I-NP	O	O
were	be	VBD	B-VP	O	O
absent	absent	JJ	B-ADJP	O	O
.	.	.	O	O	O
The	The	DT	B-NP	O	O
HIV-1	HIV-1	NN	I-NP	O	O
mutant	mutant	JJ	I-NP	O	O
virus	virus	NN	I-NP	O	O
containing	contain	VBG	B-VP	O	O
both	both	CC	O	O	O
NF	NF	NN	B-NP	B-protein	O
kappa	kappa	NN	I-NP	I-protein	O
B	B	NN	I-NP	I-protein	O
and	and	CC	O	O	O
NFAT-1	NFAT-1	NN	B-NP	B-protein	O
deletion	deletion	NN	B-NP	O	O
was	be	VBD	B-VP	O	O
able	able	JJ	B-ADJP	O	O
to	to	TO	B-VP	O	O
replicate	replicate	VB	I-VP	O	O
although	although	IN	B-SBAR	O	O
at	at	IN	B-PP	O	O
a	a	DT	B-NP	O	O
much	much	RB	I-NP	O	O
decreased	decrease	VBN	I-NP	O	O
growth	growth	NN	I-NP	O	O
rate	rate	NN	I-NP	O	O
,	,	,	O	O	O
while	while	IN	B-SBAR	O	O
the	the	DT	B-NP	O	O
deletion	deletion	NN	I-NP	O	O
of	of	IN	B-PP	O	O
NFAT-1	NFAT-1	NN	B-NP	B-protein	O
alone	alone	RB	B-ADVP	O	O
increased	increase	VBD	B-VP	O	O
the	the	DT	B-NP	O	O
viral	viral	JJ	I-NP	O	O
growth	growth	NN	I-NP	O	O
rate	rate	NN	I-NP	O	O
in	in	IN	B-PP	O	O
Jurkat	Jurkat	NN	B-NP	B-cell_line	O
cells	cell	NNS	I-NP	I-cell_line	O
.	.	.	O	O	O
Neither	Neither	CC	O	O	O
deletion	deletion	NN	B-NP	O	O
of	of	IN	B-PP	O	O
NF	NF	NN	B-NP	B-protein	O
kappa	kappa	NN	I-NP	I-protein	O
B	B	NN	I-NP	I-protein	O
nor	nor	CC	O	O	O
deletion	deletion	NN	B-NP	O	O
of	of	IN	B-PP	O	O
NFAT-1	NFAT-1	NN	B-NP	B-protein	O
decreased	decrease	VBD	B-VP	O	O
activation	activation	NN	B-NP	O	O
of	of	IN	B-PP	O	O
viral	viral	JJ	B-NP	O	O
replication	replication	NN	I-NP	O	O
by	by	IN	B-PP	O	O
phorbol	phorbol	NN	B-NP	O	O
ester	ester	NN	I-NP	O	O
.	.	.	O	O	O
The	The	DT	B-NP	O	O
NF	NF	NN	I-NP	B-DNA	O
kappa	kappa	NN	I-NP	I-DNA	O
B	B	NN	I-NP	I-DNA	O
independent	independent	JJ	I-NP	I-DNA	O
cis-acting	cis-acting	JJ	I-NP	I-DNA	O
sequences	sequence	NNS	I-NP	I-DNA	O
in	in	IN	B-PP	O	O
HIV-1	HIV-1	NN	B-NP	B-DNA	O
LTR	LTR	NN	I-NP	I-DNA	O
responsive	responsive	JJ	B-ADJP	O	O
to	to	TO	B-PP	O	O
T-cell	T-cell	NN	B-NP	O	O
activation	activation	NN	I-NP	O	O
.	.	.	O	O	O
The	The	DT	B-NP	O	O
rate	rate	NN	I-NP	O	O
of	of	IN	B-PP	O	O
transcription	transcription	NN	B-NP	O	O
initiation	initiation	NN	I-NP	O	O
directed	direct	VBN	B-VP	O	O
by	by	IN	B-PP	O	O
the	the	DT	B-NP	O	O
long	long	JJ	I-NP	B-DNA	O
terminal	terminal	JJ	I-NP	I-DNA	O
repeat	repeat	NN	I-NP	I-DNA	O
-LRB-	(	-LRB-	O	O	O
LTR	LTR	NN	B-NP	B-DNA	O
-RRB-	)	-RRB-	O	O	O
of	of	IN	B-PP	O	O
HIV-1	HIV-1	NN	B-NP	O	O
increases	increase	NNS	I-NP	O	O
in	in	IN	B-PP	O	O
response	response	NN	I-PP	O	O
to	to	TO	I-PP	O	O
mitogenic	mitogenic	JJ	B-NP	O	O
stimuli	stimulus	NNS	I-NP	O	O
of	of	IN	B-PP	O	O
T	T	NN	B-NP	B-cell_type	O
cells	cell	NNS	I-NP	I-cell_type	O
.	.	.	O	O	O
Here	Here	RB	B-ADVP	O	O
we	we	PRP	B-NP	O	O
show	show	VBP	B-VP	O	O
that	that	IN	B-SBAR	O	O
the	the	DT	B-NP	O	O
response	response	NN	I-NP	O	O
of	of	IN	B-PP	O	O
the	the	DT	B-NP	O	O
HIV-1	HIV-1	NN	I-NP	B-DNA	O
LTR	LTR	NN	I-NP	I-DNA	O
may	may	MD	B-VP	O	B-SPECCUE
be	be	VB	I-VP	O	O
governed	govern	VBN	I-VP	O	O
by	by	IN	B-PP	O	O
two	two	CD	B-NP	O	O
independent	independent	JJ	I-NP	O	O
sequences	sequence	NNS	I-NP	O	O
located	located	JJ	B-ADJP	O	O
5	5	CD	B-NP	O	O
'	'	,	B-NP	O	O
to	to	TO	B-PP	O	O
the	the	DT	B-NP	O	O
site	site	NN	I-NP	O	O
of	of	IN	B-PP	O	O
transcription	transcription	NN	B-NP	B-DNA	O
initiation	initiation	NN	I-NP	I-DNA	O
sequences	sequence	NNS	I-NP	I-DNA	O
that	that	WDT	B-NP	O	O
bind	bind	VBP	B-VP	O	O
either	either	CC	O	O	O
NFAT-1	NFAT-1	NN	B-NP	B-protein	O
or	or	CC	O	O	O
NF	NF	NN	B-NP	B-protein	O
kappa	kappa	NN	I-NP	I-protein	O
B	B	NN	I-NP	I-protein	O
.	.	.	O	O	O
These	These	DT	B-NP	O	O
transcripts	transcript	NNS	I-NP	O	O
initiate	initiate	VBP	B-VP	O	O
from	from	IN	B-PP	O	O
one	one	CD	B-NP	O	O
of	of	IN	B-PP	O	O
two	two	CD	B-NP	O	O
promoters	promoter	NNS	I-NP	B-DNA	O
,	,	,	O	O	O
Cp	Cp	NN	B-NP	B-DNA	O
or	or	CC	O	O	O
Wp	Wp	NN	B-NP	B-DNA	O
,	,	,	O	O	O
that	that	WDT	B-NP	O	O
function	function	VBP	B-VP	O	O
in	in	IN	B-PP	O	O
a	a	DT	B-NP	O	O
mutually	mutually	RB	I-NP	O	O
exclusive	exclusive	JJ	I-NP	O	O
fashion	fashion	NN	I-NP	O	O
.	.	.	O	O	O
During	During	IN	B-PP	O	O
latent	latent	JJ	O	O	O
Epstein-Barr	Epstein-Barr	JJ	B-NP	O	O
virus	virus	NN	I-NP	O	O
-LRB-	(	-LRB-	O	O	O
EBV	EBV	NN	B-NP	O	O
-RRB-	)	-RRB-	O	O	O
infection	infection	NN	B-NP	O	O
of	of	IN	B-PP	O	O
human	human	JJ	B-NP	B-cell_type	O
B	B	NN	I-NP	I-cell_type	O
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type	O
,	,	,	O	O	O
six	six	CD	B-NP	O	O
viral	viral	JJ	I-NP	B-protein	O
nuclear	nuclear	JJ	I-NP	I-protein	O
antigen	antigen	NN	I-NP	I-protein	O
-LRB-	(	-LRB-	O	O	O
EBNAs	EBNA	NNS	B-NP	B-protein	O
-RRB-	)	-RRB-	O	O	O
are	be	VBP	B-VP	O	O
expressed	express	VBN	I-VP	O	O
from	from	IN	B-PP	O	O
long	long	JJ	B-NP	B-RNA	O
primary	primary	JJ	I-NP	I-RNA	O
transcripts	transcript	NNS	I-NP	I-RNA	O
by	by	IN	B-PP	O	O
means	mean	NNS	I-PP	O	O
of	of	IN	I-PP	O	O
alternative	alternative	JJ	B-NP	O	O
splicing	splicing	NN	I-NP	O	O
and	and	CC	O	O	O
alternative	alternative	JJ	B-NP	B-DNA	O
polyadenylylation	polyadenylylation	NN	I-NP	I-DNA	O
sites	site	NNS	I-NP	I-DNA	O
.	.	.	O	O	O
Role	Role	NN	B-NP	O	O
for	for	IN	B-PP	O	O
the	the	DT	B-NP	O	O
Epstein-Barr	Epstein-Barr	JJ	I-NP	B-protein	O
virus	virus	NN	I-NP	I-protein	O
nuclear	nuclear	JJ	I-NP	I-protein	O
antigen	antigen	NN	I-NP	I-protein	O
2	2	CD	I-NP	I-protein	O
in	in	IN	B-PP	O	O
viral	viral	JJ	B-NP	B-DNA	O
promoter	promoter	NN	I-NP	I-DNA	O
switching	switching	NN	I-NP	O	O
during	during	IN	B-PP	O	O
initial	initial	JJ	B-NP	O	O
stages	stage	NNS	I-NP	O	O
of	of	IN	B-PP	O	O
infection	infection	NN	B-NP	O	O
.	.	.	O	O	O
These	These	DT	B-NP	O	O
results	result	NNS	I-NP	O	O
support	support	VBP	B-VP	O	O
a	a	DT	B-NP	O	O
model	model	NN	I-NP	O	O
for	for	IN	B-PP	O	O
viral	viral	JJ	B-NP	B-DNA	O
promoter	promoter	NN	I-NP	I-DNA	O
switching	switching	NN	I-NP	O	O
during	during	IN	B-PP	O	O
the	the	DT	B-NP	O	O
initial	initial	JJ	I-NP	O	O
stages	stage	NNS	I-NP	O	O
of	of	IN	B-PP	O	O
infection	infection	NN	B-NP	O	O
in	in	IN	B-PP	O	O
which	which	WDT	B-NP	O	O
Wp	Wp	NN	B-NP	B-DNA	O
activity	activity	NN	I-NP	O	O
leads	lead	VBZ	B-VP	O	O
to	to	TO	B-PP	O	O
the	the	DT	B-NP	O	O
expression	expression	NN	I-NP	O	O
of	of	IN	B-PP	O	O
EBNA	EBNA	NN	B-NP	B-protein	O
2	2	CD	I-NP	I-protein	O
,	,	,	O	O	O
followed	follow	VBN	B-VP	O	O
by	by	IN	B-PP	O	O
activation	activation	NN	B-NP	O	O
of	of	IN	B-PP	O	O
Cp	Cp	NN	B-NP	B-DNA	O
through	through	IN	B-PP	O	O
the	the	DT	B-NP	O	O
EBNA	EBNA	NN	I-NP	B-DNA	O
2-dependent	2-dependent	JJ	I-NP	I-DNA	O
enhancer	enhancer	NN	I-NP	I-DNA	O
.	.	.	O	O	O
These	These	DT	B-NP	O	O
studies	study	NNS	I-NP	O	O
have	have	VBP	B-VP	O	O
been	be	VBN	I-VP	O	O
extended	extend	VBN	I-VP	O	O
to	to	TO	I-VP	O	O
show	show	VB	I-VP	O	O
that	that	IN	B-SBAR	O	O
-LRB-	(	-LRB-	B-LST	O	O
i	i	LS	I-LST	O	O
-RRB-	)	-RRB-	O	O	O
a	a	DT	B-NP	O	O
mutant	mutant	JJ	I-NP	O	O
EBV	EBV	NN	I-NP	O	O
strain	strain	NN	I-NP	O	O
lacking	lack	VBG	B-VP	O	O
the	the	DT	B-NP	O	O
gene	gene	NN	I-NP	O	O
encoding	encode	VBG	B-VP	O	O
EBNA	EBNA	NN	B-NP	B-protein	O
2	2	CD	I-NP	I-protein	O
fails	fail	VBZ	B-VP	O	O
to	to	TO	I-VP	O	O
switch	switch	VB	I-VP	O	O
from	from	IN	B-PP	O	O
Wp	Wp	NN	B-NP	B-DNA	O
to	to	TO	B-PP	O	O
Cp	Cp	NN	B-NP	B-DNA	O
usage	usage	NN	I-NP	O	O
in	in	IN	B-PP	O	O
primary	primary	JJ	B-NP	B-cell_type	O
B	B	NN	I-NP	I-cell_type	O
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type	O
,	,	,	O	O	O
although	although	IN	B-SBAR	O	O
the	the	DT	B-NP	O	O
virus	virus	NN	I-NP	O	O
contains	contain	VBZ	B-VP	O	O
a	a	DT	B-NP	O	O
functional	functional	JJ	I-NP	O	O
Cp	Cp	NN	I-NP	B-DNA	O
;	;	:	O	O	O
-LRB-	(	-LRB-	B-LST	O	O
ii	ii	LS	I-LST	O	O
-RRB-	)	-RRB-	O	O	O
a	a	DT	B-NP	O	O
region	region	NN	I-NP	O	O
from	from	IN	B-PP	O	O
-429	-429	CD	B-NP	B-DNA	O
to	to	TO	I-NP	I-DNA	O
-245	-245	CD	I-NP	I-DNA	O
base	base	NN	I-NP	I-DNA	O
pairs	pair	NNS	I-NP	I-DNA	O
upstream	upstream	JJ	B-ADJP	O	O
of	of	IN	B-PP	O	O
Cp	Cp	NN	B-NP	B-DNA	O
is	be	VBZ	B-VP	O	O
essential	essential	JJ	B-ADJP	O	O
for	for	IN	B-PP	O	O
Cp	Cp	NN	B-NP	B-DNA	O
activity	activity	NN	I-NP	O	O
in	in	IN	B-PP	O	O
B	B	NN	B-NP	B-cell_type	O
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type	O
,	,	,	O	O	O
but	but	CC	O	O	O
only	only	RB	B-PP	O	O
in	in	IN	I-PP	O	O
the	the	DT	B-NP	O	O
context	context	NN	I-NP	O	O
of	of	IN	B-PP	O	O
upstream	upstream	JJ	B-NP	B-DNA	O
and	and	CC	I-NP	I-DNA	O
downstream	downstream	JJ	I-NP	I-DNA	O
sequences	sequence	NNS	I-NP	I-DNA	O
;	;	:	O	O	O
-LRB-	(	-LRB-	B-LST	O	O
iii	iii	LS	I-LST	O	O
-RRB-	)	-RRB-	O	O	O
this	this	DT	B-NP	O	O
region	region	NN	I-NP	O	O
contains	contain	VBZ	B-VP	O	O
an	an	DT	B-NP	O	O
EBNA	EBNA	NN	I-NP	B-DNA	O
2-dependent	2-dependent	JJ	I-NP	I-DNA	O
enhancer	enhancer	NN	I-NP	I-DNA	O
;	;	:	O	O	O
and	and	CC	O	O	O
-LRB-	(	-LRB-	B-LST	O	O
iv	iv	LS	I-LST	O	O
-RRB-	)	-RRB-	O	O	O
DNase	DNase	NN	B-NP	B-protein	O
I	I	CD	I-NP	I-protein	O
protection	protection	NN	I-NP	O	O
employing	employ	VBG	B-VP	O	O
nuclear	nuclear	JJ	B-NP	O	O
extracts	extract	NNS	I-NP	O	O
from	from	IN	B-PP	O	O
B	B	NN	B-NP	B-cell_type	O
and	and	CC	O	I-cell_type	O
T	T	NN	B-NP	I-cell_type	O
lymphocytes	lymphocyte	NNS	B-NP	I-cell_type	O
revealed	reveal	VBD	B-VP	O	O
a	a	DT	B-NP	O	O
B-cell-specific	B-cell-specific	JJ	I-NP	B-DNA	O
footprint	footprint	NN	I-NP	I-DNA	O
in	in	IN	B-PP	O	O
the	the	DT	B-NP	O	O
region	region	NN	I-NP	O	O
of	of	IN	B-PP	O	O
the	the	DT	B-NP	O	O
EBNA	EBNA	NN	I-NP	B-DNA	O
2-dependent	2-dependent	JJ	I-NP	I-DNA	O
enhancer	enhancer	NN	I-NP	I-DNA	O
.	.	.	O	O	O
Wp	Wp	NN	B-NP	B-DNA	O
is	be	VBZ	B-VP	O	O
exclusively	exclusively	RB	I-VP	O	O
utilized	utilize	VBN	I-VP	O	O
during	during	IN	B-PP	O	O
the	the	DT	B-NP	O	O
initial	initial	JJ	I-NP	O	O
stages	stage	NNS	I-NP	O	O
of	of	IN	B-PP	O	O
infection	infection	NN	B-NP	O	O
of	of	IN	B-PP	O	O
primary	primary	JJ	B-NP	B-cell_type	O
B	B	NN	I-NP	I-cell_type	O
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type	O
,	,	,	O	O	O
followed	follow	VBN	B-VP	O	O
by	by	IN	B-PP	O	O
a	a	DT	B-NP	O	O
switch	switch	NN	I-NP	O	O
to	to	TO	B-PP	O	O
Cp	Cp	NN	B-NP	B-DNA	O
usage	usage	NN	I-NP	O	O
.	.	.	O	O	O
We	We	PRP	B-NP	O	O
have	have	VBP	B-VP	O	O
analyzed	analyze	VBN	I-VP	O	O
the	the	DT	B-NP	O	O
functional	functional	JJ	I-NP	B-protein	O
domains	domain	NNS	I-NP	I-protein	O
of	of	IN	B-PP	O	O
the	the	DT	B-NP	O	O
minimal	minimal	JJ	I-NP	B-DNA	O
Thy-1	Thy-1	NN	I-NP	I-DNA	O
promoter	promoter	NN	I-NP	I-DNA	O
and	and	CC	O	O	O
show	show	VBP	B-VP	O	O
that	that	IN	B-SBAR	O	O
the	the	DT	B-NP	O	O
dominant	dominant	JJ	I-NP	B-DNA	O
promoter	promoter	NN	I-NP	I-DNA	O
elements	element	NNS	I-NP	I-DNA	O
consist	consist	VBP	B-VP	O	O
of	of	IN	B-PP	O	O
multiple	multiple	JJ	B-NP	B-DNA	O
binding	bind	VBG	I-NP	I-DNA	O
sites	site	NNS	I-NP	I-DNA	O
for	for	IN	B-PP	O	O
the	the	DT	B-NP	O	O
transcription	transcription	NN	I-NP	B-protein	O
factor	factor	NN	I-NP	I-protein	O
Sp1	Sp1	NN	I-NP	B-protein	O
,	,	,	O	O	O
an	an	DT	B-NP	O	O
inverted	invert	VBN	I-NP	O	O
CCAAT	CCAAT	NN	I-NP	B-DNA	O
box	box	NN	I-NP	I-DNA	O
,	,	,	O	O	O
and	and	CC	O	O	O
sequences	sequence	NNS	B-NP	O	O
proximal	proximal	JJ	B-ADJP	O	O
to	to	TO	B-PP	O	O
the	the	DT	B-NP	O	O
transcription	transcription	NN	I-NP	B-DNA	O
start	start	NN	I-NP	I-DNA	O
site	site	NN	I-NP	I-DNA	O
.	.	.	O	O	O
It	It	PRP	B-NP	O	O
can	can	MD	B-VP	O	O
only	only	RB	I-VP	O	O
be	be	VB	I-VP	O	O
activated	activate	VBN	I-VP	O	O
in	in	IN	B-PP	O	O
a	a	DT	B-NP	O	O
tissue-specific	tissue-specific	JJ	I-NP	O	O
manner	manner	NN	I-NP	O	O
by	by	IN	B-PP	O	O
elements	element	NNS	B-NP	O	O
that	that	WDT	B-NP	O	O
lie	lie	VBP	B-VP	O	O
downstream	downstream	RB	B-ADJP	O	O
of	of	IN	B-PP	O	O
the	the	DT	B-NP	O	O
initiation	initiation	NN	I-NP	B-DNA	O
site	site	NN	I-NP	I-DNA	O
.	.	.	O	O	O
Our	Our	PRP$	B-NP	O	O
results	result	NNS	I-NP	O	O
show	show	VBP	B-VP	O	O
that	that	IN	B-SBAR	O	O
the	the	DT	B-NP	O	O
structure	structure	NN	I-NP	O	O
of	of	IN	B-PP	O	O
this	this	DT	B-NP	O	O
promoter	promoter	NN	I-NP	B-DNA	O
only	only	RB	B-ADVP	O	O
permits	permit	VBZ	B-VP	O	O
productive	productive	JJ	B-NP	O	O
interactions	interaction	NNS	I-NP	O	O
of	of	IN	B-PP	O	O
the	the	DT	B-NP	O	O
two	two	CD	I-NP	O	O
transcription	transcription	NN	I-NP	B-protein	O
factors	factor	NNS	I-NP	I-protein	O
Sp1	Sp1	NN	B-NP	B-protein	O
and	and	CC	O	O	O
CP1	CP1	NN	B-NP	B-protein	O
with	with	IN	B-PP	O	O
the	the	DT	B-NP	O	O
basal	basal	JJ	I-NP	O	O
transcription	transcription	NN	I-NP	O	O
machinery	machinery	NN	I-NP	O	O
in	in	IN	B-PP	O	O
the	the	DT	I-PP	O	O
presence	presence	NN	I-PP	O	O
of	of	IN	I-PP	O	O
enhancer	enhancer	NN	B-NP	B-DNA	O
sequences	sequence	NNS	I-NP	I-DNA	O
.	.	.	O	O	O
DNase	DNase	NN	B-NP	B-protein	O
I	I	CD	I-NP	I-protein	O
and	and	CC	I-NP	O	O
gel	gel	NN	I-NP	O	O
mobility	mobility	NN	I-NP	O	O
shift	shift	NN	I-NP	O	O
assays	assay	NNS	I-NP	O	O
show	show	VBP	B-VP	O	O
the	the	DT	B-NP	O	O
binding	binding	NN	I-NP	O	O
of	of	IN	B-PP	O	O
a	a	DT	B-NP	O	O
number	number	NN	I-NP	O	O
of	of	IN	B-PP	O	O
nuclear	nuclear	JJ	B-NP	B-protein	O
factors	factor	NNS	I-NP	I-protein	O
to	to	TO	B-PP	O	O
these	these	DT	B-NP	O	O
elements	element	NNS	I-NP	B-DNA	O
,	,	,	O	O	O
including	include	VBG	B-PP	O	O
Sp1	Sp1	NN	B-NP	B-protein	O
and	and	CC	O	O	O
CP1	CP1	NN	B-NP	B-protein	O
.	.	.	O	O	O
The	The	DT	B-NP	O	O
functional	functional	JJ	I-NP	B-protein	O
domains	domain	NNS	I-NP	I-protein	O
of	of	IN	B-PP	O	O
the	the	DT	B-NP	O	O
murine	murine	JJ	I-NP	B-DNA	O
Thy-1	Thy-1	NN	I-NP	I-DNA	O
gene	gene	NN	I-NP	I-DNA	O
promoter	promoter	NN	I-NP	I-DNA	O
.	.	.	O	O	O
Using	Use	VBG	B-VP	O	O
transgenic	transgenic	JJ	B-NP	O	O
mice	mouse	NNS	I-NP	O	O
,	,	,	O	O	O
we	we	PRP	B-NP	O	O
show	show	VBP	B-VP	O	O
that	that	IN	B-SBAR	O	O
this	this	DT	B-NP	O	O
promoter	promoter	NN	I-NP	B-DNA	O
does	do	VBZ	B-VP	O	O
not	not	RB	I-VP	O	O
confer	confer	VB	I-VP	O	O
any	any	DT	B-NP	O	O
tissue	tissue	NN	I-NP	O	O
specificity	specificity	NN	I-NP	O	O
and	and	CC	O	O	O
is	be	VBZ	B-VP	O	O
active	active	JJ	B-ADJP	O	O
only	only	RB	B-PP	O	O
in	in	IN	I-PP	O	O
a	a	DT	B-NP	O	O
position-dependent	position-dependent	JJ	I-NP	O	O
manner	manner	NN	I-NP	O	O
.	.	.	O	O	O
The	The	DT	B-NP	O	O
Thy-1	Thy-1	NN	I-NP	B-DNA	O
gene	gene	NN	I-NP	I-DNA	O
promoter	promoter	NN	I-NP	I-DNA	O
resembles	resemble	VBZ	B-VP	O	O
a	a	DT	B-NP	O	O
``	``	``	I-NP	B-DNA	O
housekeeping	housekeeping	JJ	I-NP	I-DNA	O
``	``	``	I-NP	I-DNA	O
promoter	promoter	NN	I-NP	I-DNA	O
in	in	IN	B-PP	O	O
that	that	IN	B-NP	O	O
it	it	PRP	B-NP	O	O
is	be	VBZ	B-VP	O	O
located	located	JJ	B-ADJP	O	O
within	within	IN	B-PP	O	O
a	a	DT	B-NP	O	O
methylation-free	methylation-free	JJ	I-NP	B-DNA	O
island	island	NN	I-NP	I-DNA	O
,	,	,	O	O	O
lacks	lack	VBZ	B-VP	O	O
a	a	DT	B-NP	O	O
canonical	canonical	JJ	I-NP	B-DNA	O
TATA	TATA	NN	I-NP	I-DNA	O
box	box	NN	I-NP	I-DNA	O
,	,	,	O	O	O
and	and	CC	O	O	O
displays	display	VBZ	B-VP	O	O
heterogeneity	heterogeneity	NN	B-NP	O	O
in	in	IN	B-PP	O	O
the	the	DT	B-NP	O	O
5'-end	5'-end	JJ	I-NP	B-RNA	O
termini	terminus	NNS	I-NP	I-RNA	O
of	of	IN	B-PP	O	O
the	the	DT	B-NP	O	O
mRNA	mRNA	NN	I-NP	B-RNA	O
.	.	.	O	O	O
When	When	WRB	B-ADVP	O	O
U937	U937	NN	B-NP	B-cell_line	O
cells	cell	NNS	I-NP	I-cell_line	O
were	be	VBD	B-VP	O	O
infected	infect	VBN	I-VP	O	O
with	with	IN	B-PP	O	O
HIV-1	HIV-1	NN	B-NP	O	O
,	,	,	O	O	O
no	no	DT	B-NP	O	O
induction	induction	NN	I-NP	O	O
of	of	IN	B-PP	O	O
NF-KB	NF-KB	NN	B-NP	B-protein	O
factor	factor	NN	I-NP	I-protein	O
was	be	VBD	B-VP	O	O
detected	detect	VBN	I-VP	O	O
,	,	,	O	O	O
whereas	whereas	IN	O	O	O
high	high	JJ	B-NP	O	O
level	level	NN	I-NP	O	O
of	of	IN	B-PP	O	O
progeny	progeny	NN	B-NP	O	O
virions	virion	NNS	I-NP	O	O
was	be	VBD	B-VP	O	O
produced	produce	VBN	I-VP	O	O
,	,	,	O	O	O
suggesting	suggest	VBG	B-VP	O	B-SPECCUE
that	that	IN	B-SBAR	O	O
this	this	DT	B-NP	O	O
factor	factor	NN	I-NP	O	O
was	be	VBD	B-VP	O	O
not	not	RB	I-VP	O	O
required	require	VBN	I-VP	O	O
for	for	IN	B-PP	O	O
viral	viral	JJ	B-NP	O	O
replication	replication	NN	I-NP	O	O
.	.	.	O	O	O
These	These	DT	B-NP	O	O
results	result	NNS	I-NP	O	O
indicate	indicate	VBP	B-VP	O	B-SPECCUE
that	that	IN	B-SBAR	O	I-SPECCUE
in	in	IN	B-PP	O	O
monocytic	monocytic	JJ	B-NP	B-cell_type	O
cell	cell	NN	I-NP	I-cell_type	O
lineage	lineage	NN	I-NP	I-cell_type	O
,	,	,	O	O	O
HIV-1	HIV-1	NN	B-NP	O	O
could	could	MD	B-VP	O	O
mimic	mimic	VB	I-VP	O	O
some	some	DT	B-NP	O	O
differentiation\/activation	differentiation/activation	NN	I-NP	O	O
stimuli	stimulus	NNS	B-NP	O	O
allowing	allow	VBG	B-VP	O	O
nuclear	nuclear	JJ	B-NP	O	O
NF-KB	NF-KB	NN	I-NP	B-protein	O
expression	expression	NN	I-NP	O	O
.	.	.	O	O	O
PMA	PMA	NN	B-NP	O	O
treatment	treatment	NN	I-NP	O	O
,	,	,	O	O	O
and	and	CC	B-CONJP	O	O
not	not	RB	I-CONJP	O	O
retinoic	retinoic	JJ	B-NP	O	O
acid	acid	NN	I-NP	O	O
treatment	treatment	NN	I-NP	O	O
of	of	IN	B-PP	O	O
the	the	DT	B-NP	O	O
U937	U937	NN	I-NP	B-cell_line	O
cells	cell	NNS	I-NP	I-cell_line	O
acts	act	VBZ	B-VP	O	O
in	in	IN	B-PP	O	O
inducing	induce	VBG	B-VP	O	O
NF-KB	NF-KB	NN	B-NP	B-protein	O
expression	expression	NN	I-NP	O	O
in	in	IN	B-PP	O	O
the	the	DT	B-NP	O	O
nuclei	nucleus	NNS	I-NP	O	O
.	.	.	O	O	O
In	In	IN	B-PP	O	O
nuclear	nuclear	JJ	B-NP	O	O
extracts	extract	NNS	I-NP	O	O
from	from	IN	B-PP	O	O
monocytes	monocyte	NNS	B-NP	B-cell_type	O
or	or	CC	O	O	O
macrophages	macrophage	NNS	B-NP	B-cell_type	O
,	,	,	O	O	O
induction	induction	NN	B-NP	O	O
of	of	IN	B-PP	O	O
NF-KB	NF-KB	NN	B-NP	B-protein	O
occurred	occur	VBD	B-VP	O	O
only	only	RB	B-SBAR	O	O
if	if	IN	I-SBAR	O	O
the	the	DT	B-NP	O	O
cells	cell	NNS	I-NP	O	O
were	be	VBD	B-VP	O	O
previously	previously	RB	I-VP	O	O
infected	infect	VBN	I-VP	O	O
with	with	IN	B-PP	O	O
HIV-1	HIV-1	NN	B-NP	O	O
.	.	.	O	O	O
The	The	DT	B-NP	O	O
production	production	NN	I-NP	O	O
of	of	IN	B-PP	O	O
human	human	JJ	B-NP	O	O
immunodeficiency	immunodeficiency	NN	I-NP	O	O
virus	virus	NN	I-NP	O	O
type	type	NN	I-NP	O	O
1	1	CD	I-NP	O	O
-LRB-	(	-LRB-	O	O	O
HIV-1	HIV-1	NN	B-NP	O	O
-RRB-	)	-RRB-	O	O	O
progeny	progeny	NN	B-NP	O	O
was	be	VBD	B-VP	O	O
followed	follow	VBN	I-VP	O	O
in	in	IN	B-PP	O	O
the	the	DT	B-NP	O	O
U937	U937	NN	I-NP	B-cell_line	O
promonocytic	promonocytic	JJ	I-NP	I-cell_line	O
cell	cell	NN	I-NP	I-cell_line	O
line	line	NN	I-NP	I-cell_line	O
after	after	IN	B-PP	O	O
stimulation	stimulation	NN	B-NP	O	O
either	either	CC	B-PP	O	O
with	with	IN	I-PP	O	O
retinoic	retinoic	JJ	B-NP	O	O
acid	acid	NN	I-NP	O	O
or	or	CC	O	O	O
PMA	PMA	NN	B-NP	O	O
,	,	,	O	O	O
and	and	CC	O	O	O
in	in	IN	B-PP	O	O
purified	purify	VBN	B-NP	O	O
human	human	JJ	I-NP	B-cell_type	O
monocytes	monocyte	NNS	B-NP	I-cell_type	O
and	and	CC	O	O	O
macrophages	macrophage	NNS	B-NP	B-cell_type	O
.	.	.	O	O	O
Electrophoretic	Electrophoretic	JJ	B-NP	O	O
mobility	mobility	NN	I-NP	O	O
shift	shift	NN	I-NP	O	O
assays	assay	NNS	I-NP	O	O
and	and	CC	O	O	O
Southwestern	Southwestern	NN	B-NP	O	O
blotting	blotting	NN	I-NP	O	O
experiments	experiment	NNS	I-NP	O	O
were	be	VBD	B-VP	O	O
used	use	VBN	I-VP	O	O
to	to	TO	B-VP	O	O
detect	detect	VB	I-VP	O	O
the	the	DT	B-NP	O	O
binding	binding	NN	I-NP	O	O
of	of	IN	B-PP	O	O
cellular	cellular	JJ	B-NP	B-protein	O
transactivation	transactivation	NN	I-NP	I-protein	O
factor	factor	NN	I-NP	I-protein	O
NF-KB	NF-KB	NN	I-NP	B-protein	O
to	to	TO	B-PP	O	O
the	the	DT	B-NP	O	O
double	double	JJ	I-NP	B-DNA	O
repeat-KB	repeat-KB	NN	I-NP	I-DNA	O
enhancer	enhancer	NN	I-NP	I-DNA	O
sequence	sequence	NN	I-NP	I-DNA	O
located	located	JJ	B-ADJP	O	O
in	in	IN	B-PP	O	O
the	the	DT	B-NP	O	O
long	long	JJ	I-NP	B-DNA	O
terminal	terminal	JJ	I-NP	I-DNA	O
repeat	repeat	NN	I-NP	I-DNA	O
.	.	.	O	O	O
Induction	Induction	NN	B-NP	O	O
of	of	IN	B-PP	O	O
NF-KB	NF-KB	NN	B-NP	B-protein	O
during	during	IN	B-PP	O	O
monocyte	monocyte	NN	B-NP	O	O
differentiation	differentiation	NN	I-NP	O	O
by	by	IN	B-PP	O	O
HIV	HIV	NN	B-NP	O	O
type	type	NN	I-NP	O	O
1	1	CD	I-NP	O	O
infection	infection	NN	I-NP	O	O
.	.	.	O	O	O
Subcloning	Subcloning	NN	B-NP	O	O
of	of	IN	B-PP	O	O
the	the	DT	B-NP	O	O
variant	variant	JJ	I-NP	B-DNA	O
NF-kappa	NF-kappa	NN	I-NP	I-DNA	O
B	B	NN	I-NP	I-DNA	O
segments	segment	NNS	I-NP	I-DNA	O
into	into	IN	B-PP	O	O
LTR-driven	LTR-driven	JJ	B-NP	B-DNA	O
CAT	CAT	NN	I-NP	I-DNA	O
expression	expression	NN	I-NP	I-DNA	O
vectors	vector	NNS	I-NP	I-DNA	O
confirmed	confirm	VBD	B-VP	O	O
a	a	DT	B-NP	O	O
correlation	correlation	NN	I-NP	O	O
between	between	IN	B-PP	O	O
promoter	promoter	NN	B-NP	O	O
activity	activity	NN	I-NP	O	O
and	and	CC	O	O	O
replicative\/cytopathic	replicative/cytopathic	JJ	B-NP	O	O
capacity	capacity	NN	I-NP	O	O
.	.	.	O	O	O
Nucleotide	Nucleotide	NN	B-NP	B-DNA	O
sequence	sequence	NN	I-NP	I-DNA	O
and	and	CC	O	O	O
PCR	PCR	NN	B-NP	O	O
analyses	analysis	NNS	I-NP	O	O
demonstrated	demonstrate	VBD	B-VP	O	O
the	the	DT	B-NP	O	O
presence	presence	NN	I-NP	O	O
of	of	IN	B-PP	O	O
novel	novel	JJ	B-NP	O	O
duplications	duplication	NNS	I-NP	O	O
or	or	CC	O	O	B-SPECCUE
deletions	deletion	NNS	B-NP	O	O
involving	involve	VBG	B-VP	O	O
the	the	DT	B-NP	O	O
NF-kappa	NF-kappa	NN	I-NP	B-DNA	O
B	B	NN	I-NP	I-DNA	O
motif	motif	NN	I-NP	I-DNA	O
.	.	.	O	O	O
These	These	DT	B-NP	O	O
changes	change	NNS	I-NP	O	O
in	in	IN	B-PP	O	O
the	the	DT	B-NP	O	O
enhancer	enhancer	NN	I-NP	B-DNA	O
element	element	NN	I-NP	I-DNA	O
were	be	VBD	B-VP	O	O
identified	identify	VBN	I-VP	O	O
in	in	IN	B-PP	O	O
the	the	DT	B-NP	O	O
original	original	JJ	I-NP	O	O
AL1	AL1	NN	I-NP	O	O
virus	virus	NN	I-NP	O	O
stock	stock	NN	I-NP	O	O
.	.	.	O	O	O
Three	Three	CD	B-NP	O	O
molecular	molecular	JJ	I-NP	O	O
clones	clone	NNS	I-NP	O	O
of	of	IN	B-PP	O	O
HIV-1	HIV-1	NN	B-NP	O	O
,	,	,	O	O	O
derived	derive	VBN	B-VP	O	O
from	from	IN	B-PP	O	O
a	a	DT	B-NP	O	O
single	single	JJ	I-NP	O	O
isolate	isolate	NN	I-NP	O	O
-LRB-	(	-LRB-	O	O	O
AL1	AL1	NN	B-NP	B-protein	O
-RRB-	)	-RRB-	O	O	O
,	,	,	O	O	O
exhibited	exhibit	VBD	B-VP	O	O
distinct	distinct	JJ	B-NP	O	O
replicative	replicative	JJ	I-NP	O	O
and	and	CC	I-NP	O	O
cytopathic	cytopathic	JJ	I-NP	O	O
properties	property	NNS	I-NP	O	O
during	during	IN	B-PP	O	O
propagation	propagation	NN	B-NP	O	O
in	in	IN	B-PP	O	O
a	a	DT	B-NP	O	O
human	human	JJ	I-NP	B-cell_line	O
T	T	NN	I-NP	I-cell_line	O
cell	cell	NN	I-NP	I-cell_line	O
line	line	NN	I-NP	I-cell_line	O
.	.	.	O	O	O
The	The	DT	B-NP	O	O
phenotypic	phenotypic	JJ	I-NP	O	O
differences	difference	NNS	I-NP	O	O
observed	observe	VBN	B-VP	O	O
were	be	VBD	B-VP	O	O
attributable	attributable	JJ	B-ADJP	O	O
,	,	,	O	O	O
in	in	IN	B-PP	O	O
large	large	JJ	B-NP	O	O
part	part	NN	I-NP	O	O
,	,	,	O	O	O
to	to	TO	B-PP	O	O
changes	change	NNS	B-NP	O	O
affecting	affect	VBG	B-VP	O	O
the	the	DT	B-NP	O	O
viral	viral	JJ	I-NP	B-DNA	O
LTR	LTR	NN	I-NP	I-DNA	O
.	.	.	O	O	O
A	A	DT	B-NP	O	O
novel	novel	JJ	I-NP	O	O
HIV-1	HIV-1	NN	I-NP	O	O
isolate	isolate	NN	I-NP	O	O
containing	contain	VBG	B-VP	O	O
alterations	alteration	NNS	B-NP	O	O
affecting	affect	VBG	B-VP	O	O
the	the	DT	B-NP	O	O
NF-kappa	NF-kappa	NN	I-NP	B-DNA	O
B	B	NN	I-NP	I-DNA	O
element	element	NN	I-NP	I-DNA	O
.	.	.	O	O	O
These	These	DT	B-NP	O	O
data	datum	NNS	I-NP	O	O
establish	establish	VBP	B-VP	O	O
for	for	IN	B-PP	O	O
the	the	DT	B-NP	O	O
first	first	JJ	I-NP	O	O
time	time	NN	I-NP	O	O
HBxAg	HBxAg	NN	B-NP	B-protein	O
as	as	IN	B-PP	O	O
an	an	DT	B-NP	O	O
antigen	antigen	NN	I-NP	O	O
in	in	IN	B-PP	O	O
the	the	DT	B-NP	O	O
cellular	cellular	JJ	I-NP	O	O
immune	immune	JJ	I-NP	O	O
response	response	NN	I-NP	O	O
.	.	.	O	O	O
Using	Use	VBG	B-VP	O	O
recombinant	recombinant	JJ	B-NP	B-protein	O
HBxAg	HBxAg	NN	I-NP	I-protein	O
protein	protein	NN	I-NP	I-protein	O
,	,	,	O	O	O
we	we	PRP	B-NP	O	O
found	find	VBD	B-VP	O	O
HBxAg-specific	HBxAg-specific	JJ	B-NP	O	O
stimulation	stimulation	NN	I-NP	O	O
of	of	IN	B-PP	O	O
peripheral	peripheral	JJ	B-NP	B-cell_type	O
blood	blood	NN	I-NP	I-cell_type	O
mononuclear	mononuclear	JJ	I-NP	I-cell_type	O
cells	cell	NNS	I-NP	I-cell_type	O
in	in	IN	B-PP	O	O
patients	patient	NNS	B-NP	O	O
with	with	IN	B-PP	O	O
acute	acute	JJ	B-NP	O	O
hepatitis	hepatitis	NN	I-NP	O	O
B	B	NN	I-NP	O	O
virus	virus	NN	I-NP	O	O
infection	infection	NN	I-NP	O	O
-LRB-	(	-LRB-	O	O	O
6	6	CD	B-NP	O	O
of	of	IN	B-PP	O	O
6	6	CD	B-NP	O	O
-RRB-	)	-RRB-	O	O	O
and	and	CC	O	O	O
chronic	chronic	JJ	B-NP	O	O
hepatitis	hepatitis	NN	I-NP	O	O
B	B	NN	I-NP	O	O
virus	virus	NN	I-NP	O	O
infection	infection	NN	I-NP	O	O
-LRB-	(	-LRB-	O	O	O
6	6	CD	B-NP	O	O
of	of	IN	B-PP	O	O
17	17	CD	B-NP	O	O
-RRB-	)	-RRB-	O	O	O
but	but	CC	B-PP	O	O
not	not	RB	B-PP	O	O
in	in	IN	I-PP	O	O
healthy	healthy	JJ	B-NP	O	O
individuals	individual	NNS	I-NP	O	O
.	.	.	O	O	O
With	With	IN	B-PP	O	O
HBxAg-specific	HBxAg-specific	JJ	B-NP	B-protein	O
synthetic	synthetic	JJ	I-NP	I-protein	O
polypeptides	polypeptide	NNS	I-NP	I-protein	O
,	,	,	O	O	O
several	several	JJ	B-NP	O	O
T-cell	T-cell	NN	I-NP	B-protein	O
epitopes	epitope	NNS	I-NP	I-protein	O
were	be	VBD	B-VP	O	O
identified	identify	VBN	I-VP	O	O
.	.	.	O	O	O
Most	Most	JJS	B-NP	O	O
were	be	VBD	B-VP	O	O
located	locate	VBN	I-VP	O	O
in	in	IN	B-PP	O	O
the	the	DT	B-NP	O	O
carboxyterminal	carboxyterminal	JJ	I-NP	B-protein	O
half	half	NN	I-NP	I-protein	O
of	of	IN	B-PP	O	O
the	the	DT	B-NP	O	O
HBxAg	HBxAg	NN	I-NP	B-protein	O
protein	protein	NN	I-NP	I-protein	O
.	.	.	O	O	O
Five	Five	CD	B-NP	O	O
T-cell	T-cell	NN	I-NP	B-cell_line	O
clones	clone	NNS	I-NP	I-cell_line	O
specific	specific	JJ	B-ADJP	O	O
for	for	IN	B-PP	O	O
a	a	DT	B-NP	O	O
T-cell	T-cell	NN	I-NP	B-protein	O
epitope	epitope	NN	I-NP	I-protein	O
located	located	JJ	B-ADJP	O	O
at	at	IN	B-PP	O	O
the	the	DT	B-NP	O	O
carboxyterminal	carboxyterminal	JJ	I-NP	B-protein	O
region	region	NN	I-NP	I-protein	O
of	of	IN	B-PP	O	O
HBxAg	HBxAg	NN	B-NP	B-protein	O
were	be	VBD	B-VP	O	O
established	establish	VBN	I-VP	O	O
and	and	CC	O	O	O
found	find	VBN	B-VP	O	O
to	to	TO	I-VP	O	O
belong	belong	VB	I-VP	O	O
to	to	TO	B-PP	O	O
the	the	DT	B-NP	O	O
CD2\/CD4-positive	CD2/CD4-positive	JJ	I-NP	B-cell_line	O
,	,	,	I-NP	I-cell_line	O
CD8-negative	CD8-negative	JJ	I-NP	I-cell_line	O
subtype	subtype	NN	I-NP	I-cell_line	O
.	.	.	O	O	O
Immune	Immune	JJ	B-NP	O	O
response	response	NN	I-NP	O	O
of	of	IN	B-PP	O	O
peripheral	peripheral	JJ	B-NP	B-cell_type	O
blood	blood	NN	I-NP	I-cell_type	O
mononuclear	mononuclear	JJ	I-NP	I-cell_type	O
cells	cell	NNS	I-NP	I-cell_type	O
to	to	TO	B-PP	O	O
HBx-antigen	HBx-antigen	NN	B-NP	B-protein	O
of	of	IN	B-PP	O	O
hepatitis	hepatitis	NN	B-NP	O	O
B	B	NN	I-NP	O	O
virus	virus	NN	I-NP	O	O
.	.	.	O	O	O
The	The	DT	B-NP	O	O
hepatitis	hepatitis	NN	I-NP	B-DNA	O
B	B	NN	I-NP	I-DNA	O
virus	virus	NN	I-NP	I-DNA	O
genome	genome	NN	I-NP	I-DNA	O
encodes	encode	VBZ	B-VP	O	O
a	a	DT	B-NP	O	O
transcriptional	transcriptional	JJ	I-NP	B-protein	O
transactivator	transactivator	NN	I-NP	I-protein	O
protein	protein	NN	I-NP	I-protein	O
designated	designate	VBN	B-VP	O	O
HBxAg	HBxAg	NN	B-NP	B-protein	O
.	.	.	O	O	O
We	We	PRP	B-NP	O	O
have	have	VBP	B-VP	O	O
investigated	investigate	VBN	I-VP	O	O
whether	whether	IN	B-SBAR	O	B-SPECCUE
this	this	DT	B-NP	O	O
antigen	antigen	NN	I-NP	O	O
is	be	VBZ	B-VP	O	O
a	a	DT	B-NP	O	O
target	target	NN	I-NP	O	O
structure	structure	NN	I-NP	O	O
for	for	IN	B-PP	O	O
human	human	JJ	B-NP	B-cell_type	O
T-lymphocytes	T-lymphocyte	NNS	I-NP	I-cell_type	O
.	.	.	O	O	O
Third	Third	RB	B-ADVP	O	O
,	,	,	O	O	O
TCF-1	TCF-1	NN	B-NP	B-protein	O
bound	bind	VBD	B-VP	O	O
specifically	specifically	RB	B-ADVP	O	O
to	to	TO	B-PP	O	O
a	a	DT	B-NP	O	O
functional	functional	JJ	I-NP	O	O
T	T	NN	I-NP	B-DNA	O
cell-specific	cell-specific	JJ	I-NP	I-DNA	O
element	element	NN	I-NP	I-DNA	O
in	in	IN	B-PP	O	O
the	the	DT	B-NP	O	O
T	T	NN	I-NP	B-DNA	O
cell	cell	NN	I-NP	I-DNA	O
receptor	receptor	NN	I-NP	I-DNA	O
alpha	alpha	NN	I-NP	I-DNA	O
-LRB-	(	-LRB-	O	I-DNA	O
TCR-alpha	TCR-alpha	NN	B-NP	I-DNA	O
-RRB-	)	-RRB-	O	I-DNA	O
enhancer	enhancer	NN	B-NP	I-DNA	O
.	.	.	O	O	O
First	First	RB	B-ADVP	O	O
,	,	,	O	O	O
deletion	deletion	NN	B-NP	O	O
analysis	analysis	NN	I-NP	O	O
revealed	reveal	VBD	B-VP	O	O
that	that	IN	B-SBAR	O	O
a	a	DT	B-NP	O	O
region	region	NN	I-NP	O	O
of	of	IN	B-PP	O	O
TCF-1	TCF-1	NN	B-NP	B-protein	O
containing	contain	VBG	B-VP	O	O
the	the	DT	B-NP	O	O
HMG	HMG	NN	I-NP	B-DNA	O
box	box	NN	I-NP	I-DNA	O
was	be	VBD	B-VP	O	O
sufficient	sufficient	JJ	B-ADJP	O	O
for	for	IN	B-PP	O	O
sequence-specific	sequence-specific	JJ	B-NP	O	O
binding	binding	NN	I-NP	O	O
.	.	.	O	O	O
Second	Second	RB	B-ADVP	O	O
,	,	,	O	O	O
by	by	IN	B-PP	O	O
high	high	JJ	B-NP	O	O
stringency	stringency	NN	I-NP	O	O
Northern	Northern	NN	I-NP	O	O
blotting	blotting	NN	I-NP	O	O
and	and	CC	O	O	O
in	in	FW	B-NP	O	O
situ	situ	FW	I-NP	O	O
hybridization	hybridization	NN	I-NP	O	O
,	,	,	O	O	O
TCF-1	TCF-1	NN	B-NP	B-protein	O
expression	expression	NN	I-NP	O	O
was	be	VBD	B-VP	O	O
shown	show	VBN	I-VP	O	O
to	to	TO	I-VP	O	O
be	be	VB	I-VP	O	O
confined	confine	VBN	I-VP	O	O
to	to	TO	B-PP	O	O
the	the	DT	B-NP	O	O
thymus	thymus	NN	I-NP	O	O
and	and	CC	B-PP	O	O
to	to	TO	B-PP	O	O
the	the	DT	B-NP	O	O
T	T	NN	I-NP	O	O
cell	cell	NN	I-NP	O	O
areas	area	NNS	I-NP	O	O
of	of	IN	B-PP	O	O
the	the	DT	B-NP	O	O
spleen	spleen	NN	I-NP	O	O
.	.	.	O	O	O
Recombinant	Recombinant	JJ	B-NP	B-protein	O
murine	murine	JJ	I-NP	I-protein	O
and	and	CC	I-NP	I-protein	O
human	human	JJ	I-NP	I-protein	O
TCF-1	TCF-1	NN	I-NP	I-protein	O
recognized	recognize	VBD	B-VP	O	O
the	the	DT	B-NP	O	O
same	same	JJ	I-NP	O	O
sequence	sequence	NN	I-NP	O	O
motif	motif	NN	I-NP	O	O
in	in	IN	B-PP	O	O
the	the	DT	B-NP	O	O
CD3-epsilon	CD3-epsilon	NN	I-NP	B-DNA	O
enhancer	enhancer	NN	I-NP	I-DNA	O
as	as	IN	B-SBAR	O	O
judged	judge	VBN	B-VP	O	O
by	by	IN	B-PP	O	O
gel	gel	NN	B-NP	O	O
retardation	retardation	NN	I-NP	O	O
and	and	CC	O	O	O
methylation	methylation	NN	B-NP	O	O
interference	interference	NN	I-NP	O	O
assays	assay	NNS	I-NP	O	O
.	.	.	O	O	O
Murine	Murine	JJ	B-NP	B-protein	O
and	and	CC	I-NP	I-protein	O
human	human	JJ	I-NP	I-protein	O
TCF-1	TCF-1	NN	I-NP	I-protein	O
displayed	display	VBD	B-VP	O	O
a	a	DT	B-NP	O	O
95.5	95.5	CD	I-NP	O	O
%	%	NN	I-NP	O	O
overall	overall	JJ	I-NP	O	O
amino	amino	JJ	I-NP	O	O
acid	acid	NN	I-NP	O	O
homology	homology	NN	I-NP	O	O
.	.	.	O	O	O
The	The	DT	B-NP	O	O
T	T	NN	I-NP	O	O
lineage-specific	lineage-specific	JJ	I-NP	O	O
expression	expression	NN	I-NP	O	O
and	and	CC	O	O	O
the	the	DT	B-NP	O	O
affinity	affinity	NN	I-NP	O	O
for	for	IN	B-PP	O	O
functional	functional	JJ	B-NP	O	O
motifs	motif	NNS	I-NP	O	O
in	in	IN	B-PP	O	O
the	the	DT	O	O	O
TCR-alpha	TCR-alpha	NN	B-NP	B-DNA	O
and	and	CC	O	I-DNA	O
CD3-epsilon	CD3-epsilon	NN	B-NP	I-DNA	O
enhancers	enhancer	NNS	B-NP	I-DNA	O
imply	imply	VBP	B-VP	O	B-SPECCUE
an	an	DT	B-NP	O	O
important	important	JJ	I-NP	O	O
role	role	NN	I-NP	O	O
for	for	IN	B-PP	O	O
TCF-1	TCF-1	NN	B-NP	B-protein	O
in	in	IN	B-PP	O	O
the	the	DT	B-NP	O	O
establishment	establishment	NN	I-NP	O	O
of	of	IN	B-PP	O	O
the	the	DT	B-NP	O	O
mature	mature	JJ	I-NP	B-cell_type	O
T	T	NN	I-NP	I-cell_type	O
cell	cell	NN	I-NP	I-cell_type	O
phenotype	phenotype	NN	I-NP	I-cell_type	O
.	.	.	O	O	O
TCF-1	TCF-1	NN	B-NP	B-protein	O
belonged	belong	VBD	B-VP	O	O
to	to	TO	B-PP	O	O
a	a	DT	B-NP	O	O
novel	novel	JJ	I-NP	O	O
family	family	NN	I-NP	O	O
of	of	IN	B-PP	O	O
genes	gene	NNS	B-NP	O	O
that	that	WDT	B-NP	O	O
contain	contain	VBP	B-VP	O	O
the	the	DT	B-NP	O	O
so-called	so-called	JJ	I-NP	O	O
high	high	JJ	I-NP	O	O
mobility	mobility	NN	I-NP	O	O
group	group	NN	I-NP	O	O
1	1	CD	I-NP	O	O
-LRB-	(	-LRB-	I-NP	O	O
HMG	HMG	NN	I-NP	B-protein	O
-RRB-	)	-RRB-	I-NP	O	O
box	box	NN	I-NP	O	O
.	.	.	O	O	O
In	In	IN	B-PP	O	O
a	a	DT	B-NP	O	O
panel	panel	NN	I-NP	O	O
of	of	IN	B-PP	O	O
human	human	JJ	B-NP	B-cell_line	O
cell	cell	NN	I-NP	I-cell_line	O
lines	line	NNS	I-NP	I-cell_line	O
,	,	,	O	O	O
TCF-1	TCF-1	NN	B-NP	B-protein	O
expression	expression	NN	I-NP	O	O
was	be	VBD	B-VP	O	O
restricted	restricted	JJ	B-ADJP	O	O
to	to	TO	B-PP	O	O
T	T	NN	B-NP	B-cell_type	O
lineage	lineage	NN	I-NP	I-cell_type	O
cells	cell	NNS	I-NP	I-cell_type	O
.	.	.	O	O	O
Two	Two	CD	B-NP	O	O
splice	splice	NN	I-NP	O	O
alternatives	alternative	NNS	I-NP	O	O
were	be	VBD	B-VP	O	O
identified	identify	VBN	I-VP	O	O
that	that	WDT	B-NP	O	O
were	be	VBD	B-VP	O	O
not	not	RB	I-VP	O	O
previously	previously	RB	I-VP	O	O
observed	observe	VBN	I-VP	O	O
in	in	IN	B-PP	O	O
human	human	JJ	B-NP	B-protein	O
TCF-1	TCF-1	NN	I-NP	I-protein	O
.	.	.	O	O	O
Here	Here	RB	B-ADVP	O	O
we	we	PRP	B-NP	O	O
report	report	VBP	B-VP	O	O
the	the	DT	B-NP	O	O
cloning	cloning	NN	I-NP	O	O
of	of	IN	B-PP	O	O
murine	murine	JJ	B-NP	B-protein	O
TCF-1	TCF-1	NN	I-NP	I-protein	O
.	.	.	O	O	O
Cloning	Cloning	NN	B-NP	O	O
of	of	IN	B-PP	O	O
murine	murine	JJ	B-NP	B-protein	O
TCF-1	TCF-1	NN	I-NP	I-protein	O
,	,	,	O	O	O
a	a	DT	B-NP	O	O
T	T	NN	I-NP	B-protein	O
cell-specific	cell-specific	JJ	I-NP	I-protein	O
transcription	transcription	NN	I-NP	I-protein	O
factor	factor	NN	I-NP	I-protein	O
interacting	interact	VBG	B-VP	O	O
with	with	IN	B-PP	O	O
functional	functional	JJ	B-NP	B-DNA	O
motifs	motif	NNS	I-NP	I-DNA	O
in	in	IN	B-PP	O	O
the	the	DT	B-NP	O	O
CD3-epsilon	CD3-epsilon	NN	I-NP	B-DNA	O
and	and	CC	I-NP	I-DNA	O
T	T	NN	I-NP	I-DNA	O
cell	cell	NN	I-NP	I-DNA	O
receptor	receptor	NN	I-NP	I-DNA	O
alpha	alpha	NN	I-NP	I-DNA	O
enhancers	enhancer	NNS	I-NP	I-DNA	O
.	.	.	O	O	O
With	With	IN	B-PP	O	O
the	the	DT	B-NP	O	O
murine	murine	JJ	I-NP	B-DNA	O
cDNA	cDNA	NN	I-NP	I-DNA	O
clones	clone	NNS	I-NP	I-DNA	O
several	several	JJ	B-NP	O	O
aspects	aspect	NNS	I-NP	O	O
of	of	IN	B-PP	O	O
TCF-1	TCF-1	NN	B-NP	B-protein	O
were	be	VBD	B-VP	O	O
analyzed	analyze	VBN	I-VP	O	O
.	.	.	O	O	O
We	We	PRP	B-NP	O	O
have	have	VBP	B-VP	O	O
recently	recently	RB	I-VP	O	O
identified	identify	VBN	I-VP	O	O
and	and	CC	O	O	O
cloned	clone	VBN	B-VP	O	O
a	a	DT	B-NP	O	O
human	human	JJ	I-NP	B-protein	O
transcription	transcription	NN	I-NP	I-protein	O
factor	factor	NN	I-NP	I-protein	O
,	,	,	O	O	O
TCF-1	TCF-1	NN	B-NP	B-protein	O
,	,	,	O	O	O
that	that	WDT	B-NP	O	O
binds	bind	VBZ	B-VP	O	O
to	to	TO	B-PP	O	O
a	a	DT	B-NP	O	O
functional	functional	JJ	I-NP	O	O
element	element	NN	I-NP	O	O
in	in	IN	B-PP	O	O
the	the	DT	B-NP	O	O
T	T	NN	I-NP	B-DNA	O
lymphocyte-specific	lymphocyte-specific	JJ	I-NP	I-DNA	O
enhancer	enhancer	NN	I-NP	I-DNA	O
of	of	IN	B-PP	O	O
CD3-epsilon	CD3-epsilon	NN	B-NP	B-protein	O
.	.	.	O	O	O
CD3-epsilon	CD3-epsilon	NN	B-NP	O	O
gene	gene	NN	I-NP	O	O
expression	expression	NN	I-NP	O	O
is	be	VBZ	B-VP	O	O
confined	confine	VBN	I-VP	O	O
to	to	TO	B-PP	O	O
the	the	DT	B-NP	O	O
T	T	NN	I-NP	B-cell_type	O
cell	cell	NN	I-NP	I-cell_type	O
lineage	lineage	NN	I-NP	I-cell_type	O
.	.	.	O	O	O
Thus	Thus	RB	B-ADVP	O	O
,	,	,	O	O	O
the	the	DT	B-NP	O	O
novel	novel	JJ	I-NP	O	O
enhancer	enhancer	NN	I-NP	B-DNA	O
element	element	NN	I-NP	I-DNA	O
identified	identify	VBN	B-VP	O	O
in	in	IN	B-PP	O	O
this	this	DT	B-NP	O	O
study	study	NN	I-NP	O	O
is	be	VBZ	B-VP	O	O
probably	probably	RB	B-ADVP	O	B-SPECCUE
a	a	DT	B-NP	O	O
target	target	NN	I-NP	B-DNA	O
site	site	NN	I-NP	I-DNA	O
for	for	IN	B-PP	O	O
both	both	CC	B-NP	O	O
positive	positive	JJ	I-NP	B-protein	O
and	and	CC	I-NP	I-protein	O
negative	negative	JJ	I-NP	I-protein	O
factors	factor	NNS	I-NP	I-protein	O
.	.	.	O	O	O
Moreover	Moreover	RB	B-ADVP	O	O
,	,	,	O	O	O
simian	simian	JJ	B-NP	O	O
virus	virus	NN	I-NP	O	O
40	40	CD	I-NP	O	O
enhancer	enhancer	NN	I-NP	O	O
activity	activity	NN	I-NP	O	O
was	be	VBD	B-VP	O	O
blocked	block	VBN	I-VP	O	O
by	by	IN	B-PP	O	O
the	the	DT	B-NP	O	O
MnlI-AluI	MnlI-AluI	NN	I-NP	B-DNA	O
fragment	fragment	NN	I-NP	I-DNA	O
in	in	IN	B-PP	O	O
HeLa	HeLa	NN	B-NP	B-cell_line	O
cells	cell	NNS	I-NP	I-cell_line	O
but	but	CC	B-PP	O	O
not	not	RB	B-PP	O	O
in	in	IN	I-PP	O	O
B	B	NN	B-NP	B-cell_type	O
cells	cell	NNS	I-NP	I-cell_type	O
.	.	.	O	O	O
Interestingly	Interestingly	RB	B-ADVP	O	O
,	,	,	O	O	O
the	the	DT	B-NP	O	O
MnlI-AluI	MnlI-AluI	NN	I-NP	B-DNA	O
fragment	fragment	NN	I-NP	I-DNA	O
could	could	MD	B-VP	O	B-SPECCUE
suppress	suppress	VB	I-VP	O	O
the	the	DT	B-NP	O	O
basal-level	basal-level	JJ	I-NP	O	O
activity	activity	NN	I-NP	O	O
of	of	IN	B-PP	O	O
the	the	DT	B-NP	O	O
conalbumin	conalbumin	NN	I-NP	B-DNA	O
promoter	promoter	NN	I-NP	I-DNA	O
in	in	IN	B-PP	O	O
both	both	CC	O	O	O
Jurkat	Jurkat	NN	B-NP	B-cell_line	O
and	and	CC	O	O	O
HeLa	HeLa	NN	B-NP	B-cell_line	O
cells	cell	NNS	B-NP	I-cell_line	O
.	.	.	O	O	O
In	In	IN	B-PP	O	O
striking	striking	JJ	B-NP	O	O
contrast	contrast	NN	I-NP	O	O
to	to	TO	B-PP	O	O
the	the	DT	B-NP	O	O
mouse	mouse	NN	I-NP	B-DNA	O
Ig	Ig	NN	I-NP	I-DNA	O
heavy-chain	heavy-chain	JJ	I-NP	I-DNA	O
enhancer	enhancer	NN	I-NP	I-DNA	O
,	,	,	O	O	O
in	in	IN	B-PP	O	O
which	which	WDT	B-NP	O	O
the	the	DT	B-NP	O	O
octamer	octamer	NN	I-NP	B-DNA	O
motif	motif	NN	I-NP	I-DNA	O
acts	act	VBZ	B-VP	O	O
as	as	IN	B-PP	O	O
a	a	DT	B-NP	O	O
B-cell-specific	B-cell-specific	JJ	I-NP	B-DNA	O
enhancer	enhancer	NN	I-NP	I-DNA	O
element	element	NN	I-NP	I-DNA	O
,	,	,	O	O	O
the	the	DT	B-NP	O	O
human	human	JJ	I-NP	B-DNA	O
enhancer	enhancer	NN	I-NP	I-DNA	O
contains	contain	VBZ	B-VP	O	O
an	an	DT	B-NP	O	O
octamerlike	octamerlike	JJ	I-NP	B-DNA	O
sequence	sequence	NN	I-NP	I-DNA	O
with	with	IN	B-PP	O	O
one	one	CD	B-NP	O	O
base	base	NN	I-NP	O	O
substitution	substitution	NN	I-NP	O	O
which	which	WDT	B-NP	O	O
bound	bind	VBD	B-VP	O	O
octamer-binding	octamer-binding	JJ	B-NP	B-protein	O
proteins	protein	NNS	I-NP	I-protein	O
with	with	IN	B-PP	O	O
only	only	RB	B-NP	O	O
very	very	RB	I-NP	O	O
low	low	JJ	I-NP	O	O
affinity	affinity	NN	I-NP	O	O
and	and	CC	O	O	O
showed	show	VBD	B-VP	O	O
no	no	DT	B-NP	O	O
enhancer	enhancer	NN	I-NP	O	O
activity	activity	NN	I-NP	O	O
of	of	IN	B-PP	O	O
its	its	PRP$	B-NP	O	O
own	own	JJ	I-NP	O	O
.	.	.	O	O	O
Positive	Positive	JJ	B-NP	O	O
and	and	CC	I-NP	O	O
negative	negative	JJ	I-NP	O	O
regulation	regulation	NN	I-NP	O	O
of	of	IN	B-PP	O	O
immunoglobulin	immunoglobulin	NN	B-NP	B-DNA	O
gene	gene	NN	I-NP	I-DNA	O
expression	expression	NN	I-NP	O	O
by	by	IN	B-PP	O	O
a	a	DT	B-NP	O	O
novel	novel	JJ	I-NP	O	O
B-cell-specific	B-cell-specific	JJ	I-NP	B-DNA	O
enhancer	enhancer	NN	I-NP	I-DNA	O
element	element	NN	I-NP	I-DNA	O
.	.	.	O	O	O
Tandem	Tandem	JJ	B-NP	O	O
copies	copy	NNS	I-NP	O	O
of	of	IN	B-PP	O	O
this	this	DT	B-NP	O	O
67-bp	67-bp	JJ	I-NP	B-DNA	O
MnlI-AluI	MnlI-AluI	NN	I-NP	I-DNA	O
fragment	fragment	NN	I-NP	I-DNA	O
,	,	,	O	O	O
when	when	WRB	B-ADVP	O	O
fused	fuse	VBN	B-VP	O	O
to	to	TO	B-PP	O	O
the	the	DT	B-NP	O	O
chloramphenicol	chloramphenicol	NN	I-NP	B-DNA	O
acetyltransferase	acetyltransferase	NN	I-NP	I-DNA	O
gene	gene	NN	I-NP	I-DNA	O
driven	drive	VBN	B-VP	O	O
by	by	IN	B-PP	O	O
the	the	DT	B-NP	O	O
conalbumin	conalbumin	NN	I-NP	B-DNA	O
promoter	promoter	NN	I-NP	I-DNA	O
,	,	,	O	O	O
stimulated	stimulate	VBD	B-VP	O	O
transcription	transcription	NN	B-NP	O	O
in	in	IN	B-PP	O	O
B	B	NN	B-NP	B-cell_type	O
cells	cell	NNS	I-NP	I-cell_type	O
but	but	CC	B-PP	O	O
not	not	RB	B-PP	O	O
in	in	IN	I-PP	O	O
Jurkat	Jurkat	NN	B-NP	B-cell_line	O
T	T	NN	I-NP	I-cell_line	O
cells	cell	NNS	I-NP	I-cell_line	O
or	or	CC	O	O	B-SPECCUE
HeLa	HeLa	NN	B-NP	B-cell_line	O
cells	cell	NNS	I-NP	I-cell_line	O
.	.	.	O	O	O
A	A	DT	B-NP	O	O
new	new	JJ	I-NP	O	O
B-cell-specific	B-cell-specific	JJ	I-NP	B-DNA	O
enhancer	enhancer	NN	I-NP	I-DNA	O
element	element	NN	I-NP	I-DNA	O
has	have	VBZ	B-VP	O	O
been	be	VBN	I-VP	O	O
identified	identify	VBN	I-VP	O	O
3	3	CD	B-NP	O	O
'	'	NNS	B-NP	O	O
of	of	IN	B-PP	O	O
E4	E4	NN	B-NP	B-protein	O
and	and	CC	O	O	O
the	the	DT	B-NP	O	O
octamerlike	octamerlike	JJ	I-NP	B-DNA	O
motifs	motif	NNS	I-NP	I-DNA	O
in	in	IN	B-PP	O	O
the	the	DT	B-NP	O	O
human	human	JJ	I-NP	B-DNA	O
immunoglobulin	immunoglobulin	NN	I-NP	I-DNA	O
heavy-chain	heavy-chain	JJ	I-NP	I-DNA	O
gene	gene	NN	I-NP	I-DNA	O
enhancer	enhancer	NN	I-NP	I-DNA	O
.	.	.	O	O	O
Gel	Gel	NN	B-NP	O	O
mobility	mobility	NN	I-NP	O	O
shift	shift	NN	I-NP	O	O
assays	assay	NNS	I-NP	O	O
using	use	VBG	B-VP	O	O
a	a	DT	B-NP	O	O
synthetic	synthetic	JJ	I-NP	B-DNA	O
E6	E6	NN	I-NP	I-DNA	O
motif	motif	NN	I-NP	I-DNA	O
detected	detect	VBD	B-VP	O	O
a	a	DT	B-NP	O	O
B-cell-specific	B-cell-specific	JJ	I-NP	B-protein	O
complex	complex	NN	I-NP	I-protein	O
in	in	IN	B-PP	O	O
addition	addition	NN	B-NP	O	O
to	to	TO	B-PP	O	O
a	a	DT	B-NP	O	O
ubiquitous	ubiquitous	JJ	I-NP	O	O
band	band	NN	I-NP	O	O
found	find	VBN	B-VP	O	O
also	also	RB	B-ADVP	O	O
in	in	IN	B-PP	O	O
T	T	NN	B-NP	B-cell_type	O
cells	cell	NNS	I-NP	I-cell_type	O
and	and	CC	O	O	O
HeLa	HeLa	NN	B-NP	B-cell_line	O
cells	cell	NNS	I-NP	I-cell_line	O
.	.	.	O	O	O
Footprinting	Footprinting	NN	B-NP	O	O
analysis	analysis	NN	I-NP	O	O
revealed	reveal	VBD	B-VP	O	O
that	that	IN	B-SBAR	O	O
the	the	DT	B-NP	O	O
identical	identical	JJ	I-NP	O	O
sequence	sequence	NN	I-NP	O	O
CCGAAACTGAAAAGG	CCGAAACTGAAAAGG	NN	I-NP	O	O
,	,	,	O	O	O
designated	designate	VBN	B-VP	O	O
E6	E6	NN	B-NP	B-DNA	O
,	,	,	O	O	O
was	be	VBD	B-VP	O	O
protected	protect	VBN	I-VP	O	O
by	by	IN	B-PP	O	O
nuclear	nuclear	JJ	B-NP	O	O
extracts	extract	NNS	I-NP	O	O
from	from	IN	B-PP	O	O
B	B	NN	B-NP	B-cell_type	O
cells	cell	NNS	I-NP	I-cell_type	O
,	,	,	O	O	O
T	T	NN	B-NP	B-cell_type	O
cells	cell	NNS	I-NP	I-cell_type	O
,	,	,	O	O	O
or	or	CC	O	O	B-SPECCUE
HeLa	HeLa	NN	B-NP	B-cell_line	O
cells	cell	NNS	I-NP	I-cell_line	O
.	.	.	O	O	O
Furthermore	Furthermore	RB	B-ADVP	O	O
,	,	,	O	O	O
a	a	DT	B-NP	O	O
mutant	mutant	JJ	I-NP	B-DNA	O
E6	E6	NN	I-NP	I-DNA	O
motif	motif	NN	I-NP	I-DNA	O
lost	lose	VBD	B-VP	O	O
both	both	CC	O	O	O
in	in	FW	B-NP	O	O
vitro	vitro	FW	I-NP	O	O
binding	binding	NN	I-NP	O	O
activity	activity	NN	I-NP	O	O
and	and	CC	B-PP	O	O
in	in	FW	B-NP	O	O
vivo	vivo	FW	I-NP	O	O
enhancer	enhancer	NN	I-NP	O	O
activity	activity	NN	I-NP	O	O
.	.	.	O	O	O
In	In	IN	B-PP	O	O
agreement	agreement	NN	I-PP	O	O
with	with	IN	I-PP	O	O
the	the	DT	B-NP	O	O
results	result	NNS	I-NP	O	O
of	of	IN	B-PP	O	O
gel	gel	NN	B-NP	O	O
retardation	retardation	NN	I-NP	O	O
assays	assay	NNS	I-NP	O	O
,	,	,	O	O	O
tandem	tandem	JJ	B-NP	O	O
copies	copy	NNS	I-NP	O	O
of	of	IN	B-PP	O	O
the	the	DT	B-NP	O	O
E6	E6	NN	I-NP	B-DNA	O
motif	motif	NN	I-NP	I-DNA	O
stimulated	stimulate	VBD	B-VP	O	O
transcription	transcription	NN	B-NP	O	O
in	in	IN	B-PP	O	O
ARH77	ARH77	NN	B-NP	B-cell_line	O
and	and	CC	O	O	O
Raji	Raji	NN	B-NP	B-cell_line	O
cells	cell	NNS	I-NP	I-cell_line	O
but	but	CC	B-PP	O	O
not	not	RB	B-PP	O	O
in	in	IN	I-PP	O	O
Jurkat	Jurkat	NN	B-NP	B-cell_line	O
or	or	CC	O	O	B-SPECCUE
HeLa	HeLa	NN	B-NP	B-cell_line	O
cells	cell	NNS	B-NP	I-cell_line	O
.	.	.	O	O	O
Oct-2	Oct-2	NN	B-NP	B-RNA	O
mRNA	mRNA	NN	I-NP	I-RNA	O
levels	level	NNS	I-NP	O	O
and	and	CC	O	O	O
both	both	CC	O	O	O
Oct-2	Oct-2	NN	B-NP	B-protein	O
and	and	CC	O	O	O
NF-kappa	NF-kappa	NN	B-NP	B-protein	O
B	B	NN	I-NP	I-protein	O
proteins	protein	NNS	I-NP	I-protein	O
in	in	IN	B-PP	O	O
nuclear	nuclear	JJ	B-NP	O	O
extracts	extract	NNS	I-NP	O	O
were	be	VBD	B-VP	O	O
not	not	RB	I-VP	O	O
altered	alter	VBN	I-VP	O	O
by	by	IN	B-PP	O	O
treatment	treatment	NN	B-NP	O	O
with	with	IN	B-PP	O	O
TGF-beta	TGF-beta	NN	B-NP	B-protein	O
.	.	.	O	O	O
The	The	DT	B-NP	O	O
effects	effect	NNS	I-NP	O	O
of	of	IN	B-PP	O	O
TGF-beta	TGF-beta	NN	B-NP	B-protein	O
on	on	IN	B-PP	O	O
two	two	CD	B-NP	O	O
transcriptional	transcriptional	JJ	I-NP	B-protein	O
regulatory	regulatory	JJ	I-NP	I-protein	O
factors	factor	NNS	I-NP	I-protein	O
,	,	,	O	O	O
Oct-2	Oct-2	NN	B-NP	B-protein	O
and	and	CC	O	O	O
nuclear	nuclear	JJ	B-NP	B-protein	O
factor	factor	NN	I-NP	I-protein	O
-LRB-	(	-LRB-	O	I-protein	O
NF	NF	NN	B-NP	I-protein	O
-RRB-	)	-RRB-	O	I-protein	O
kappa	kappa	NN	B-NP	I-protein	O
B	B	NN	I-NP	I-protein	O
,	,	,	O	O	O
known	know	VBN	B-VP	O	O
to	to	TO	I-VP	O	O
be	be	VB	I-VP	O	O
important	important	JJ	B-ADJP	O	O
in	in	IN	B-PP	O	O
Ig	Ig	NN	B-NP	B-DNA	O
gene	gene	NN	I-NP	I-DNA	O
transcription	transcription	NN	I-NP	O	O
were	be	VBD	B-VP	O	O
examined	examine	VBN	I-VP	O	O
.	.	.	O	O	O
These	These	DT	B-NP	O	O
findings	finding	NNS	I-NP	O	O
demonstrate	demonstrate	VBP	B-VP	O	O
that	that	IN	B-SBAR	O	O
TGF-beta	TGF-beta	NN	B-NP	B-protein	O
decreases	decrease	VBZ	B-VP	O	O
B	B	NN	B-NP	B-cell_type	O
lymphocyte	lymphocyte	NN	I-NP	I-cell_type	O
Ig	Ig	NN	I-NP	B-protein	O
secretion	secretion	NN	I-NP	O	O
by	by	IN	B-PP	O	O
inhibiting	inhibit	VBG	B-VP	O	O
the	the	DT	B-NP	O	O
synthesis	synthesis	NN	I-NP	O	O
of	of	IN	B-PP	O	O
Ig	Ig	NN	B-NP	B-RNA	O
mRNA	mRNA	NN	I-NP	I-RNA	O
and	and	CC	O	O	O
inhibiting	inhibit	VBG	B-VP	O	O
the	the	DT	B-NP	O	O
switch	switch	NN	I-NP	O	O
from	from	IN	B-PP	O	O
the	the	DT	B-NP	O	O
membrane	membrane	NN	I-NP	B-RNA	O
form	form	NN	I-NP	I-RNA	O
to	to	TO	B-PP	O	O
the	the	DT	B-NP	O	O
secreted	secrete	VBN	I-NP	B-RNA	O
forms	form	NNS	I-NP	I-RNA	O
of	of	IN	B-PP	O	O
mu	mu	NN	B-NP	B-RNA	O
and	and	CC	O	I-RNA	O
gamma	gamma	NN	B-NP	I-RNA	O
mRNA	mRNA	NN	B-NP	I-RNA	O
.	.	.	O	O	O
In	In	IN	B-PP	O	O
contrast	contrast	NN	B-NP	O	O
,	,	,	O	O	O
levels	level	NNS	B-NP	O	O
of	of	IN	B-PP	O	O
the	the	DT	B-NP	O	O
transcriptional	transcriptional	JJ	I-NP	B-protein	O
factor	factor	NN	I-NP	I-protein	O
AP-1	AP-1	NN	I-NP	B-protein	O
,	,	,	O	O	O
which	which	WDT	B-NP	O	O
is	be	VBZ	B-VP	O	O
not	not	RB	I-VP	O	O
known	know	VBN	I-VP	O	O
to	to	TO	I-VP	O	O
be	be	VB	I-VP	O	O
important	important	JJ	B-ADJP	O	O
in	in	IN	B-PP	O	O
B	B	NN	B-NP	B-cell_type	O
cell	cell	NN	I-NP	I-cell_type	O
Ig	Ig	NN	I-NP	B-protein	O
production	production	NN	I-NP	O	O
,	,	,	O	O	O
were	be	VBD	B-VP	O	O
reduced	reduce	VBN	I-VP	O	O
by	by	IN	B-PP	O	O
TGF-beta	TGF-beta	NN	B-NP	B-protein	O
.	.	.	O	O	O
The	The	DT	B-NP	O	O
mechanism	mechanism	NN	I-NP	O	O
by	by	IN	B-PP	O	O
which	which	WDT	B-NP	O	O
TGF-beta	TGF-beta	NN	B-NP	B-protein	O
inhibits	inhibit	VBZ	B-VP	O	O
Ig	Ig	NN	B-NP	B-protein	O
chain	chain	NN	I-NP	I-protein	O
synthesis	synthesis	NN	I-NP	O	O
is	be	VBZ	B-VP	O	O
unclear	unclear	JJ	B-ADJP	O	B-SPECCUE
although	although	IN	B-SBAR	O	O
it	it	PRP	B-NP	O	O
does	do	VBZ	B-VP	O	O
not	not	RB	I-VP	O	O
involve	involve	VB	I-VP	O	O
inhibition	inhibition	NN	B-NP	O	O
of	of	IN	B-PP	O	O
the	the	DT	B-NP	O	O
binding	binding	NN	I-NP	O	O
of	of	IN	B-PP	O	O
NF-kappa	NF-kappa	NN	B-NP	B-protein	O
B	B	NN	I-NP	I-protein	O
or	or	CC	O	O	O
Oct-2	Oct-2	NN	B-NP	B-protein	O
to	to	TO	B-PP	O	O
their	their	PRP$	B-NP	O	O
respective	respective	JJ	I-NP	O	O
target	target	NN	I-NP	B-DNA	O
sequences	sequence	NNS	I-NP	I-DNA	O
.	.	.	O	O	O
Nuclear	Nuclear	JJ	B-NP	O	O
run-on	run-on	JJ	I-NP	O	O
experiments	experiment	NNS	I-NP	O	O
demonstrated	demonstrate	VBD	B-VP	O	O
decreased	decrease	VBN	B-NP	O	O
transcription	transcription	NN	I-NP	O	O
of	of	IN	B-PP	O	O
kappa	kappa	NN	B-NP	B-protein	O
L	L	NN	I-NP	I-protein	O
chain	chain	NN	I-NP	I-protein	O
.	.	.	O	O	O
Furthermore	Furthermore	RB	B-ADVP	O	O
,	,	,	O	O	O
a	a	DT	B-NP	O	O
significant	significant	JJ	I-NP	O	O
decrease	decrease	NN	I-NP	O	O
in	in	IN	B-PP	O	O
the	the	DT	B-NP	O	O
switch	switch	NN	I-NP	O	O
from	from	IN	B-PP	O	O
the	the	DT	B-NP	O	O
membrane	membrane	NN	I-NP	B-RNA	O
forms	form	NNS	I-NP	I-RNA	O
of	of	IN	B-PP	O	O
mu	mu	NN	B-NP	O	O
and	and	CC	O	O	O
gamma	gamma	NN	B-NP	O	O
to	to	TO	B-PP	O	O
their	their	PRP$	B-NP	O	O
respective	respective	JJ	I-NP	O	O
secreted	secreted	JJ	I-NP	B-RNA	O
forms	form	NNS	I-NP	I-RNA	O
was	be	VBD	B-VP	O	O
noted	note	VBN	I-VP	O	O
in	in	IN	B-PP	O	O
the	the	DT	I-PP	O	O
presence	presence	NN	I-PP	O	O
of	of	IN	I-PP	O	O
TGF-beta	TGF-beta	NN	B-NP	B-protein	O
.	.	.	O	O	O
Transforming	Transform	VBG	B-NP	B-protein	O
growth	growth	NN	I-NP	I-protein	O
factor-beta	factor-beta	NN	I-NP	I-protein	O
suppresses	suppress	VBZ	B-VP	O	O
human	human	JJ	B-NP	B-protein	O
B	B	NN	I-NP	I-protein	O
lymphocyte	lymphocyte	NN	I-NP	I-protein	O
Ig	Ig	NN	I-NP	I-protein	O
production	production	NN	I-NP	O	O
by	by	IN	B-PP	O	O
inhibiting	inhibit	VBG	B-VP	O	O
synthesis	synthesis	NN	B-NP	O	O
and	and	CC	O	O	O
the	the	DT	B-NP	O	O
switch	switch	NN	I-NP	O	O
from	from	IN	B-PP	O	O
the	the	DT	B-NP	O	O
membrane	membrane	NN	I-NP	B-RNA	O
form	form	NN	I-NP	I-RNA	O
to	to	TO	B-PP	O	O
the	the	DT	B-NP	O	O
secreted	secrete	VBN	I-NP	B-RNA	O
form	form	NN	I-NP	I-RNA	O
of	of	IN	B-PP	O	O
Ig	Ig	NN	B-NP	B-RNA	O
mRNA	mRNA	NN	I-NP	I-RNA	O
.	.	.	O	O	O
The	The	DT	B-NP	O	O
addition	addition	NN	I-NP	O	O
of	of	IN	B-PP	O	O
TGF-beta	TGF-beta	NN	B-NP	B-protein	O
to	to	TO	B-PP	O	O
human	human	JJ	B-NP	B-cell_line	O
B	B	NN	I-NP	I-cell_line	O
lymphocyte	lymphocyte	NN	I-NP	I-cell_line	O
cultures	culture	NNS	I-NP	I-cell_line	O
stimulated	stimulate	VBN	B-VP	O	O
with	with	IN	B-PP	O	O
Staphylococcus	Staphylococcus	FW	B-NP	O	O
aureus	aureus	FW	I-NP	O	O
Cowan	Cowan	NN	I-NP	O	O
strain	strain	NN	I-NP	O	O
I	I	CD	I-NP	O	O
and	and	CC	O	O	O
IL-2	IL-2	NN	B-NP	B-protein	O
completely	completely	RB	B-ADVP	O	O
inhibited	inhibit	VBD	B-VP	O	O
B	B	NN	B-NP	B-cell_type	O
cell	cell	NN	I-NP	I-cell_type	O
Ig	Ig	NN	I-NP	B-protein	O
secretion	secretion	NN	I-NP	O	O
-LRB-	(	-LRB-	O	O	O
greater	great	JJR	B-ADVP	O	O
than	than	IN	B-PP	O	O
90	90	CD	B-NP	O	O
%	%	NN	I-NP	O	O
-RRB-	)	-RRB-	O	O	O
and	and	CC	O	O	O
decreased	decrease	VBD	B-VP	O	O
B	B	NN	B-NP	O	O
cell	cell	NN	I-NP	O	O
surface	surface	NN	I-NP	O	O
IgM	IgM	NN	B-NP	B-protein	O
,	,	,	O	O	O
IgD	IgD	NN	B-NP	B-protein	O
,	,	,	O	O	O
kappa	kappa	NN	B-NP	B-protein	O
L	L	NN	I-NP	I-protein	O
chain	chain	NN	I-NP	I-protein	O
,	,	,	O	O	O
and	and	CC	O	O	O
lambda	lambda	NN	B-NP	B-protein	O
L	L	NN	I-NP	I-protein	O
chain	chain	NN	I-NP	I-protein	O
expression	expression	NN	I-NP	O	O
.	.	.	O	O	O
Transforming	Transform	VBG	B-NP	B-protein	O
growth	growth	NN	I-NP	I-protein	O
factor-beta	factor-beta	NN	I-NP	I-protein	O
-LRB-	(	-LRB-	O	O	O
TGF-beta	TGF-beta	NN	B-NP	B-protein	O
-RRB-	)	-RRB-	O	O	O
inhibits	inhibit	VBZ	B-VP	O	O
B	B	NN	B-NP	B-cell_type	O
cell	cell	NN	I-NP	I-cell_type	O
Ig	Ig	NN	I-NP	B-protein	O
secretion	secretion	NN	I-NP	O	O
and	and	CC	O	O	O
reduces	reduce	VBZ	B-VP	O	O
B	B	NN	B-NP	B-cell_type	O
cell	cell	NN	I-NP	I-cell_type	O
membrane	membrane	NN	I-NP	O	O
Ig	Ig	NN	I-NP	O	O
expression	expression	NN	I-NP	O	O
.	.	.	O	O	O
Internal	Internal	JJ	B-NP	O	O
labeling	labeling	NN	I-NP	O	O
with	with	IN	B-PP	O	O
-LRB-	[	-LRB-	O	O	O
35S	35S	NN	B-NP	O	O
-RRB-	]	-RRB-	I-NP	O	O
methionine	methionine	NN	I-NP	O	O
and	and	CC	I-NP	O	O
immunoprecipitation	immunoprecipitation	NN	I-NP	O	O
with	with	IN	B-PP	O	O
anti-IgM	anti-IgM	JJ	B-NP	B-protein	O
,	,	,	I-NP	O	O
anti-kappa	anti-kappa	JJ	I-NP	B-protein	O
,	,	,	I-NP	O	O
and	and	CC	I-NP	O	O
anti-lambda	anti-lambda	JJ	I-NP	B-protein	O
antibodies	antibody	NNS	I-NP	I-protein	O
revealed	reveal	VBD	B-VP	O	O
a	a	DT	B-NP	O	O
striking	striking	JJ	I-NP	O	O
reduction	reduction	NN	I-NP	O	O
in	in	IN	B-PP	O	O
kappa	kappa	NN	B-NP	B-protein	O
L	L	NN	I-NP	I-protein	O
chain	chain	NN	I-NP	I-protein	O
in	in	IN	B-PP	O	O
the	the	DT	I-PP	O	O
presence	presence	NN	I-PP	O	O
of	of	IN	I-PP	O	O
TGF-beta	TGF-beta	NN	B-NP	B-protein	O
.	.	.	O	O	O
In	In	IN	B-PP	O	O
contrast	contrast	NN	B-NP	O	O
,	,	,	O	O	O
TGF-beta	TGF-beta	NN	B-NP	B-protein	O
had	have	VBD	B-VP	O	O
only	only	RB	B-NP	O	O
minimal	minimal	JJ	I-NP	O	O
effects	effect	NNS	I-NP	O	O
on	on	IN	B-PP	O	O
two	two	CD	B-NP	O	O
other	other	JJ	I-NP	O	O
B	B	NN	I-NP	B-protein	O
cell	cell	NN	I-NP	I-protein	O
membrane	membrane	NN	I-NP	I-protein	O
proteins	protein	NNS	I-NP	I-protein	O
,	,	,	O	O	O
HLA-DR	HLA-DR	NN	B-NP	B-protein	O
and	and	CC	O	O	O
CD20	CD20	NN	B-NP	B-protein	O
.	.	.	O	O	O
Northern	Northern	NN	B-NP	O	O
blot	blot	NN	I-NP	O	O
analysis	analysis	NN	I-NP	O	O
of	of	IN	B-PP	O	O
RNA	RNA	NN	B-NP	B-RNA	O
purified	purify	VBN	B-VP	O	O
from	from	IN	B-PP	O	O
B	B	NN	B-NP	B-cell_type	O
cells	cell	NNS	I-NP	I-cell_type	O
treated	treat	VBN	B-VP	O	O
with	with	IN	B-PP	O	O
TGF-beta	TGF-beta	NN	B-NP	B-protein	O
for	for	IN	B-PP	O	O
varying	vary	VBG	B-NP	O	O
time	time	NN	I-NP	O	O
intervals	interval	NNS	I-NP	O	O
revealed	reveal	VBD	B-VP	O	O
a	a	DT	B-NP	O	O
significant	significant	JJ	I-NP	O	O
decrease	decrease	NN	I-NP	O	O
in	in	IN	B-PP	O	O
steady	steady	JJ	B-NP	O	O
state	state	NN	I-NP	O	O
kappa	kappa	NN	I-NP	O	O
and	and	CC	I-NP	O	O
lambda	lambda	NN	I-NP	O	O
L	L	NN	I-NP	O	O
chain	chain	NN	I-NP	O	O
mRNA	mRNA	NN	I-NP	O	O
levels	level	NNS	I-NP	O	O
.	.	.	O	O	O
A	A	DT	B-NP	O	O
less	less	RBR	I-NP	O	O
pronounced	pronounced	JJ	I-NP	O	O
reduction	reduction	NN	I-NP	O	O
in	in	IN	B-PP	O	O
lambda	lambda	NN	B-NP	B-protein	O
L	L	NN	I-NP	I-protein	O
chain	chain	NN	I-NP	I-protein	O
and	and	CC	O	O	O
microH	microH	NN	B-NP	B-protein	O
chain	chain	NN	I-NP	I-protein	O
was	be	VBD	B-VP	O	O
also	also	RB	I-VP	O	O
noted	note	VBN	I-VP	O	O
.	.	.	O	O	O
The	The	DT	B-NP	O	O
induction	induction	NN	I-NP	O	O
of	of	IN	B-PP	O	O
AP1	AP1	NN	B-NP	B-protein	O
by	by	IN	B-PP	O	O
okadaic	okadaic	JJ	B-NP	O	O
acid	acid	NN	I-NP	O	O
suggests	suggest	VBZ	B-VP	O	B-SPECCUE
that	that	IN	B-SBAR	O	O
protein	protein	NN	B-NP	B-protein	O
phosphatases	phosphatas	NNS	I-NP	I-protein	O
1	1	CD	B-NP	I-protein	O
and	and	CC	O	I-protein	O
2A	2A	NN	B-NP	I-protein	O
-LRB-	(	-LRB-	O	O	O
PP1	PP1	NN	B-NP	B-protein	O
and	and	CC	O	O	O
PP2A	PP2A	NN	B-NP	B-protein	O
-RRB-	)	-RRB-	O	O	O
may	may	MD	B-VP	O	O
be	be	VB	I-VP	O	O
involved	involve	VBN	I-VP	O	O
in	in	IN	B-PP	O	O
T	T	NN	B-NP	O	O
cell	cell	NN	I-NP	O	O
activation	activation	NN	I-NP	O	O
as	as	IN	B-PP	O	O
important	important	JJ	B-NP	O	O
negative	negative	JJ	I-NP	O	O
regulators	regulator	NNS	I-NP	O	O
of	of	IN	B-PP	O	O
the	the	DT	B-NP	O	O
transcription	transcription	NN	I-NP	B-protein	O
factor	factor	NN	I-NP	I-protein	O
AP1	AP1	NN	I-NP	B-protein	O
.	.	.	O	O	O
Similar	Similar	JJ	B-ADJP	O	O
to	to	TO	B-PP	O	O
its	its	PRP$	B-NP	O	O
effect	effect	NN	I-NP	O	O
on	on	IN	B-PP	O	O
the	the	DT	B-NP	O	O
induction	induction	NN	I-NP	O	O
of	of	IN	B-PP	O	O
AP1	AP1	NN	B-NP	B-protein	O
by	by	IN	B-PP	O	O
okadaic	okadaic	JJ	B-NP	O	O
acid	acid	NN	I-NP	O	O
,	,	,	O	O	O
PMA	PMA	NN	B-NP	O	O
inhibits	inhibit	VBZ	B-VP	O	O
the	the	DT	B-NP	O	O
induction	induction	NN	I-NP	O	O
of	of	IN	B-PP	O	O
c-jun	c-jun	NN	B-NP	B-RNA	O
mRNA	mRNA	NN	I-NP	I-RNA	O
by	by	IN	B-PP	O	O
okadaic	okadaic	JJ	B-NP	O	O
acid	acid	NN	I-NP	O	O
.	.	.	O	O	O
Transfection	Transfection	NN	B-NP	O	O
of	of	IN	B-PP	O	O
c-jun	c-jun	NN	B-NP	B-DNA	O
promoter	promoter	NN	I-NP	I-DNA	O
constructs	construct	NNS	I-NP	I-DNA	O
confirmed	confirm	VBD	B-VP	O	O
the	the	DT	B-NP	O	O
marked	marked	JJ	I-NP	O	O
difference	difference	NN	I-NP	O	O
between	between	IN	B-PP	O	O
PMA	PMA	NN	B-NP	O	O
and	and	CC	O	O	O
okadaic	okadaic	JJ	B-NP	O	O
acid	acid	NN	I-NP	O	O
in	in	IN	B-PP	O	O
inducing	induce	VBG	B-VP	O	O
c-jun	c-jun	NN	B-NP	B-DNA	O
transcription	transcription	NN	I-NP	O	O
.	.	.	O	O	O
To	To	TO	B-VP	O	O
examine	examine	VB	I-VP	O	O
the	the	DT	B-NP	O	O
role	role	NN	I-NP	O	O
of	of	IN	B-PP	O	O
protein	protein	NN	B-NP	B-protein	O
phosphatases	phosphatas	NNS	I-NP	I-protein	O
in	in	IN	B-PP	O	O
T	T	NN	B-NP	O	O
cell	cell	NN	I-NP	O	O
activation	activation	NN	I-NP	O	O
,	,	,	O	O	O
Jurkat	Jurkat	NN	B-NP	B-cell_line	O
cells	cell	NNS	I-NP	I-cell_line	O
were	be	VBD	B-VP	O	O
treated	treat	VBN	I-VP	O	O
with	with	IN	B-PP	O	O
okadaic	okadaic	JJ	B-NP	O	O
acid	acid	NN	I-NP	O	O
,	,	,	O	O	O
an	an	DT	B-NP	O	O
inhibitor	inhibitor	NN	I-NP	O	O
of	of	IN	B-PP	O	O
type	type	NN	B-NP	B-protein	O
1	1	CD	I-NP	I-protein	O
and	and	CC	I-NP	I-protein	O
2A	2A	NN	I-NP	I-protein	O
phosphatases	phosphatas	NNS	I-NP	I-protein	O
,	,	,	O	O	O
and	and	CC	O	O	O
nuclear	nuclear	JJ	B-NP	O	O
extracts	extract	NNS	I-NP	O	O
were	be	VBD	B-VP	O	O
examined	examine	VBN	I-VP	O	O
for	for	IN	B-PP	O	O
the	the	DT	B-NP	O	O
presence	presence	NN	I-NP	O	O
of	of	IN	B-PP	O	O
AP1	AP1	NN	B-NP	B-protein	O
as	as	IN	B-PP	O	O
a	a	DT	B-NP	O	O
measure	measure	NN	I-NP	O	O
of	of	IN	B-PP	O	O
early	early	JJ	B-NP	O	O
T	T	NN	I-NP	O	O
cell	cell	NN	I-NP	O	O
activation	activation	NN	I-NP	O	O
.	.	.	O	O	O
Okadaic	Okadaic	JJ	B-NP	O	O
acid	acid	NN	I-NP	O	O
was	be	VBD	B-VP	O	O
found	find	VBN	I-VP	O	O
to	to	TO	I-VP	O	O
be	be	VB	I-VP	O	O
a	a	DT	B-NP	O	O
potent	potent	JJ	I-NP	O	O
inducer	inducer	NN	I-NP	O	O
of	of	IN	B-PP	O	O
AP1	AP1	NN	B-NP	B-protein	O
.	.	.	O	O	O
Inhibition	Inhibition	NN	B-NP	O	O
of	of	IN	B-PP	O	O
protein	protein	NN	B-NP	B-protein	O
phosphatases	phosphatas	NNS	I-NP	I-protein	O
by	by	IN	B-PP	O	O
okadaic	okadaic	JJ	B-NP	O	O
acid	acid	NN	I-NP	O	O
induces	induce	VBZ	B-VP	O	O
AP1	AP1	NN	B-NP	B-protein	O
in	in	IN	B-PP	O	O
human	human	JJ	B-NP	B-cell_type	O
T	T	NN	I-NP	I-cell_type	O
cells	cell	NNS	I-NP	I-cell_type	O
.	.	.	O	O	O
Okadaic	Okadaic	JJ	B-NP	O	O
acid	acid	NN	I-NP	O	O
treatment	treatment	NN	I-NP	O	O
was	be	VBD	B-VP	O	O
found	find	VBN	I-VP	O	O
to	to	TO	I-VP	O	O
dramatically	dramatically	RB	I-VP	O	O
increase	increase	VB	I-VP	O	O
mRNA	mRNA	NN	B-NP	B-RNA	O
transcripts	transcript	NNS	I-NP	I-RNA	O
of	of	IN	B-PP	O	O
the	the	DT	B-NP	O	O
jun	jun	NN	I-NP	B-protein	O
family	family	NN	I-NP	I-protein	O
of	of	IN	B-PP	O	O
proto-oncogenes	proto-oncogene	NNS	B-NP	B-DNA	O
including	include	VBG	B-PP	O	O
c-jun	c-jun	NN	B-NP	B-DNA	O
,	,	,	O	O	O
junD	junD	NN	B-NP	B-DNA	O
,	,	,	O	O	O
and	and	CC	O	O	O
junB	junB	NN	B-NP	B-DNA	O
and	and	CC	O	O	O
to	to	TO	B-PP	O	O
a	a	DT	B-NP	O	O
lesser	less	JJR	I-NP	O	O
extent	extent	NN	I-NP	O	O
the	the	DT	B-NP	O	O
fos	fos	NN	I-NP	B-DNA	O
family	family	NN	I-NP	I-DNA	O
including	include	VBG	B-PP	O	O
c-fos	c-fos	NN	B-NP	B-DNA	O
and	and	CC	O	O	O
fra-1	fra-1	NN	B-NP	B-DNA	O
.	.	.	O	O	O
By	By	IN	B-PP	O	O
comparison	comparison	NN	B-NP	O	O
,	,	,	O	O	O
PMA	PMA	NN	B-NP	O	O
is	be	VBZ	B-VP	O	O
a	a	DT	B-NP	O	O
very	very	RB	I-NP	O	O
inefficient	inefficient	JJ	I-NP	O	O
inducer	inducer	NN	I-NP	O	O
of	of	IN	B-PP	O	O
the	the	DT	B-NP	O	O
jun	jun	NN	I-NP	B-DNA	O
gene	gene	NN	I-NP	I-DNA	O
family	family	NN	I-NP	I-DNA	O
in	in	IN	B-PP	O	O
Jurkat	Jurkat	NN	B-NP	B-cell_line	O
cells	cell	NNS	I-NP	I-cell_line	O
.	.	.	O	O	O
In	In	IN	B-PP	O	O
contrast	contrast	NN	B-NP	O	O
to	to	TO	B-PP	O	O
phorbol	phorbol	NN	B-NP	O	O
esters	ester	NNS	I-NP	O	O
such	such	JJ	B-PP	O	O
as	as	IN	I-PP	O	O
phorbol	phorbol	NN	B-NP	O	O
myristate	myristate	NN	I-NP	O	O
acetate	acetate	NN	I-NP	O	O
-LRB-	(	-LRB-	O	O	O
PMA	PMA	NN	B-NP	O	O
-RRB-	)	-RRB-	O	O	O
,	,	,	O	O	O
the	the	DT	B-NP	O	O
induction	induction	NN	I-NP	O	O
of	of	IN	B-PP	O	O
AP1	AP1	NN	B-NP	B-protein	O
by	by	IN	B-PP	O	O
okadaic	okadaic	JJ	B-NP	O	O
acid	acid	NN	I-NP	O	O
occurs	occur	VBZ	B-VP	O	O
predominantly	predominantly	RB	B-PP	O	O
by	by	IN	I-PP	O	O
transcriptional	transcriptional	JJ	B-NP	O	O
activation	activation	NN	I-NP	O	O
of	of	IN	B-PP	O	O
the	the	DT	O	O	O
jun	jun	NN	B-NP	B-DNA	O
and	and	CC	O	I-DNA	O
fos	fos	NN	B-NP	I-DNA	O
family	family	NN	B-NP	I-DNA	O
of	of	IN	B-PP	O	O
proto-oncogenes	proto-oncogene	NNS	B-NP	B-DNA	O
.	.	.	O	O	O
Surprisingly	Surprisingly	RB	B-ADVP	O	O
,	,	,	O	O	O
while	while	IN	B-SBAR	O	O
the	the	DT	B-NP	O	O
addition	addition	NN	I-NP	O	O
of	of	IN	B-PP	O	O
phytohemagglutinin	phytohemagglutinin	NN	B-NP	B-protein	O
further	further	RBR	B-ADVP	O	O
enhanced	enhance	VBD	B-VP	O	O
the	the	DT	B-NP	O	O
induction	induction	NN	I-NP	O	O
of	of	IN	B-PP	O	O
AP1	AP1	NN	B-NP	B-protein	O
,	,	,	O	O	O
the	the	DT	B-NP	O	O
addition	addition	NN	I-NP	O	O
of	of	IN	B-PP	O	O
PMA	PMA	NN	B-NP	O	O
inhibited	inhibit	VBD	B-VP	O	O
it	it	PRP	B-NP	O	O
.	.	.	O	O	O
Upon	Upon	IN	B-PP	O	O
cotransfection	cotransfection	NN	B-NP	O	O
into	into	IN	B-PP	O	O
non-T	non-T	JJ	B-NP	B-cell_type	O
cells	cell	NNS	I-NP	I-cell_type	O
,	,	,	O	O	O
TCF-1	TCF-1	NN	B-NP	B-protein	O
could	could	MD	B-VP	O	B-SPECCUE
transactivate	transactivate	VB	I-VP	O	O
through	through	IN	B-PP	O	O
its	its	PRP$	B-NP	O	O
cognate	cognate	JJ	I-NP	O	O
motif	motif	NN	I-NP	O	O
.	.	.	O	O	O
These	These	DT	B-NP	O	O
results	result	NNS	I-NP	O	O
identify	identify	VBP	B-VP	O	O
TCF-1	TCF-1	NN	B-NP	B-protein	O
as	as	IN	B-PP	O	O
a	a	DT	B-NP	O	O
T	T	NN	I-NP	B-protein	O
cell-specific	cell-specific	JJ	I-NP	I-protein	O
transcription	transcription	NN	I-NP	I-protein	O
factor	factor	NN	I-NP	I-protein	O
,	,	,	O	O	O
which	which	WDT	B-NP	O	O
might	might	MD	B-VP	O	B-SPECCUE
play	play	VB	I-VP	O	O
a	a	DT	B-NP	O	O
role	role	NN	I-NP	O	O
in	in	IN	B-PP	O	O
the	the	DT	B-NP	O	O
establishment	establishment	NN	I-NP	O	O
of	of	IN	B-PP	O	O
the	the	DT	B-NP	O	O
mature	mature	JJ	I-NP	B-cell_type	O
T	T	NN	I-NP	I-cell_type	O
cell	cell	NN	I-NP	I-cell_type	O
phenotype	phenotype	NN	I-NP	I-cell_type	O
.	.	.	O	O	O
CD3-epsilon	CD3-epsilon	NN	B-NP	O	O
expression	expression	NN	I-NP	O	O
is	be	VBZ	B-VP	O	O
controlled	control	VBN	I-VP	O	O
by	by	IN	B-PP	O	O
a	a	DT	B-NP	O	O
downstream	downstream	JJ	I-NP	B-DNA	O
T	T	NN	I-NP	I-DNA	O
lymphocyte-specific	lymphocyte-specific	JJ	I-NP	I-DNA	O
enhancer	enhancer	NN	I-NP	I-DNA	O
element	element	NN	I-NP	I-DNA	O
.	.	.	O	O	O
We	We	PRP	B-NP	O	O
report	report	VBP	B-VP	O	O
the	the	DT	B-NP	O	O
identification	identification	NN	I-NP	O	O
of	of	IN	B-PP	O	O
a	a	DT	B-NP	O	O
T	T	NN	I-NP	B-protein	O
cell-specific	cell-specific	JJ	I-NP	I-protein	O
transcription	transcription	NN	I-NP	I-protein	O
factor	factor	NN	I-NP	I-protein	O
,	,	,	O	O	O
TCF-1	TCF-1	NN	B-NP	B-protein	O
,	,	,	O	O	O
binding	bind	VBG	B-VP	O	O
to	to	TO	B-PP	O	O
this	this	DT	B-NP	O	O
element	element	NN	I-NP	O	O
.	.	.	O	O	O
Identification	Identification	NN	B-NP	O	O
and	and	CC	I-NP	O	O
cloning	cloning	NN	I-NP	O	O
of	of	IN	B-PP	O	O
TCF-1	TCF-1	NN	B-NP	B-protein	O
,	,	,	O	O	O
a	a	DT	B-NP	O	O
T	T	NN	I-NP	B-protein	O
lymphocyte-specific	lymphocyte-specific	JJ	I-NP	I-protein	O
transcription	transcription	NN	I-NP	I-protein	O
factor	factor	NN	I-NP	I-protein	O
containing	contain	VBG	B-VP	O	O
a	a	DT	B-NP	O	O
sequence-specific	sequence-specific	JJ	I-NP	B-protein	O
HMG	HMG	NN	I-NP	I-protein	O
box	box	NN	I-NP	I-protein	O
.	.	.	O	O	O
TCF-1	TCF-1	NN	B-NP	B-protein	O
contained	contain	VBD	B-VP	O	O
a	a	DT	B-NP	O	O
single	single	JJ	I-NP	O	O
DNA-binding	DNA-binding	JJ	I-NP	B-protein	O
HMG	HMG	NN	I-NP	I-protein	O
box	box	NN	I-NP	I-protein	O
most	most	RBS	B-ADJP	O	O
closely	closely	RB	I-ADJP	O	O
related	related	JJ	I-ADJP	O	O
to	to	TO	B-PP	O	O
similar	similar	JJ	B-NP	O	O
boxes	box	NNS	I-NP	O	O
in	in	IN	B-PP	O	O
the	the	DT	B-NP	O	O
putative	putative	JJ	I-NP	B-DNA	B-SPECCUE
mammalian	mammalian	JJ	I-NP	I-DNA	O
sex-determining	sex-determining	JJ	I-NP	I-DNA	O
gene	gene	NN	I-NP	I-DNA	O
SRY	SRY	NN	I-NP	B-DNA	O
and	and	CC	B-PP	O	O
in	in	IN	B-PP	O	O
the	the	DT	B-NP	O	O
Schizosaccharomyces	Schizosaccharomyces	FW	I-NP	B-DNA	O
pombe	pombe	FW	I-NP	I-DNA	O
Mc	Mc	NN	I-NP	I-DNA	O
mating	mating	NN	I-NP	I-DNA	O
type	type	NN	I-NP	I-DNA	O
gene	gene	NN	I-NP	I-DNA	O
.	.	.	O	O	O
TCF-1	TCF-1	NN	B-NP	B-RNA	O
mRNA	mRNA	NN	I-NP	I-RNA	O
was	be	VBD	B-VP	O	O
expressed	express	VBN	I-VP	O	O
uniquely	uniquely	RB	B-ADVP	O	O
in	in	IN	B-PP	O	O
T	T	NN	B-NP	B-cell_type	O
lymphocytes	lymphocyte	NNS	I-NP	I-cell_type	O
.	.	.	O	O	O
The	The	DT	B-NP	O	O
multimerized	multimerized	JJ	I-NP	B-protein	O
recognition	recognition	NN	I-NP	I-protein	O
motif	motif	NN	I-NP	I-protein	O
of	of	IN	B-PP	O	O
TCF-1	TCF-1	NN	B-NP	B-protein	O
constituted	constitute	VBD	B-VP	O	O
a	a	DT	B-NP	O	O
T	T	NN	I-NP	B-DNA	O
cell-specific	cell-specific	JJ	I-NP	I-DNA	O
enhancer	enhancer	NN	I-NP	I-DNA	O
.	.	.	O	O	O
Subsequent	Subsequent	JJ	B-NP	O	O
cloning	cloning	NN	I-NP	O	O
of	of	IN	B-PP	O	O
TCF-1	TCF-1	NN	B-NP	B-protein	O
identified	identify	VBD	B-VP	O	O
three	three	CD	B-NP	O	O
splice	splice	NN	I-NP	B-protein	O
alternatives	alternative	NNS	I-NP	I-protein	O
.	.	.	O	O	O
